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Introduction

Staphylococcus aureus is an Opportunistic Pathogen. Staphylococcus aureus is a
Gram-positive, non-sporeforming bacteria, first observed in the 1880s [Ogston, 1984].
Cells of this organism arrange as clusters of round golden spheres, or cocci; and have a
range in diameter of between 0.7 µm to 1.2 µm. The genome of S. aureus is
approximately 2.8 Mbp with a G+C content of 33% [Gill et al., 2005; Kuroda et al.,
2001]. As a facultative anaerobe, S. aureus can respire in the presence of oxygen, or
undergo fermentation in the absence of oxygen. Optimal growth of S. aureus is achieved
at temperatures of 25°C to 43°C and at pH levels of 4.8 to 9.4 [Novick, 2006].

Manifestation of S. aureus Infection. S. aureus is ubiquitous throughout nature as both
a pathogen and commensal organism of humans, which are its natural reservoir [Lowry,
1998].

Approximately

30%

of

the

adult

population

harbors

this

microbe

asymptomatically in the anterior of their nares. This carrier population contributes to the
transmission of S. aureus primarily through direct contact with sites of infection or areas
of colonization [Wertheim et al., 2004]. The manifestation of S. aureus infection or
disease is remarkably broad and diverse, ranging from localized acute soft tissue
infections to life threating septicemia. Soft tissue or localized wound infections
commonly begin as a small pimple at the site of infection. Often these lead to boils,
carbuncles, or furuncles as the infection progresses [Lowry, 1998]. Further, these initial
1

foci of infection can rapidly lead to more invasive diseases, which can often result in the
irreversible degradation of host tissues and muscle. Severe S. aureus infections can
manifest as necrotizing diseases (e.g. necrotizing fasciitis and necrotizing pneumonia),
systemic bacteremia, endocarditis, osteomyelitis and septic arthritis [Fowler et al., 2005].
The pathogenic success of S. aureus is largely based on regulatory networks that
coordinate the expression of bacterial virulence factors. This is achieved by global
regulators that modulate temporal gene expression according to changes in the
environment [Chan and Foster, 1998; Novick, 2006; Yarwood et al., 2001].

Antibiotic Resistance in S. aureus. S. aureus is a remarkably successful pathogen, with
overwhelming resistance to antibiotic therapies. The incidence of infections due to
antibiotic resistant strains has achieved epidemic proportions, and is primarily the
consequence of methicillin resistant S. aureus, or MRSA, strains [Chambers, 2001;
Kaplan et al., 2005; Klevens et al., 2007]. In 2004, MRSA accounted for nearly 60% of
all S. aureus infections reported for patients staying in intensive care units [National
Nosocomial Infections Surveillance (NNIS) System Report, 2004. Methicillin resistant S.
aureus is now believed to be the leading cause of death by a single infectious agent in the
United States [Kobayashi and DeLeo, 2009]. The antibiotic penicillin was first
introduced in the early 1940s, and by 1944, the first resistant isolates of S. aureus to
emerged [Barber and Rozwadowska-Dowzenko, 1948]. These strains developed in
healthcare settings from an acquired penicillinase encoded on a plasmid [Ridley et al.,
1970]. Penicillinase inactivates the functional β-lactam ring though a targeted cleavage
event, negating the activity of the drug [Discussion on Penicillin, 1994; Wu et al., 2001].
2

Despite these efforts, by 1960 80% of all S. aureus strains were penicillin resistant, and
were spreading at pandemic proportions throughout both the community and hospital
settings [Ridley et al., 1970]. As of 2008, more than 90% of all S. aureus isolates
possessed penicillinase-mediated penicillin resistance [Tenover, 2008]. In 1959,
methicillin was developed for the treatment of penicillin resistant S. aureus infections
[Batchelor et al., 1959]. Methicillin is a semi-synthetic antimicrobial with an orthodimethoxyphenyl side group, which prevents penicillinase access to the β-lactam ring by
steric hindrance [Klein and Finland, 1963]. The use of methicillin for treating penicillin
resistant S. aureus infections was short lived, and within two years of its introduction the
first resistant strain was isolated [Jevons, 1961]. In S. aureus, methicillin resistance
occurs through the chromosomally encoded mecA gene, which specifies a low affinity
binding protein PBP2a. The β-lactam activity of methicillin inactivates native penicillin
binding proteins, which is counteracted through the transpeptidase activity of PBP2a.
Thus, the controlled expression of PBP2a allows cell wall synthesis to continue even at
high β-lactam concentrations [Ito et al., 1999; Wu et al., 2001]. The mecA gene resides on
the mobile cassette element SCCmec, and integrates into the chromosome at a locus of
unknown function, orfX. The procurement of SCCmec by S. aureus confers resistance to
the entire class of β-lactam antibiotics, and is presumed to have initially evolved in
Staphylococcus sciuri [Wu et al., 2001]. Therefore, glycopeptides are often the preferred
therapy for severe MRSA infections and include the antibiotic vancomycin. Vancomycin
targets cell wall transpeptidation by blocking or altering the D-Ala-D-Ala motif of the
glycan chains. Isolation of S. aureus strains with reduced vancomycin susceptibility
(VISA) was first reported in 1996 in Japan [Reduced susceptibility of Staphylococcus
3

aureus to vancomycin, 1997]. Reduced vancomycin susceptibility evolved in S. aureus
according to the selective pressures associated with the over utilization of the antibiotic to
treat S. aureus infections. Many studies attribute this to minor changes in key regulatory
elements involved in cell wall metabolism [Cui et al., 2009; Meehl et al., 2007; Mwangi
et al., 2007]. True vancomycin resistant S. aureus (VRSA) first surfaced in the United
States in 2002, presenting a serious threat public health [Staphylococcus aureus resistant
to vancomycin–United States, 2002, vancomycin-resistant Staphylococcus aureus–
Pennsylvania, 2002]. Resistance in VRSA strains is primarily mediated by the vanA gene,
which seems to be acquired through a conjugation event with enterococcal species [Evers
et al., 1996].

Community-Acquired S. aureus. S. aureus infections have historically been confined to
the hospital setting, largely populated with immunocompromised individuals [Deresinski,
2005]. However, in 1999 highly virulent MRSA strains were reported in the community,
outside of the nosocomial setting [Four Pediatric Deaths From Community-Acquired
Methicillin-Resistant Staphylococcus aureus—Minnesota and North Dakota, 1999;
Fridkin et al., 2005]. Infections caused by Community-associated S. aureus strains (CAMRSA) began emerging in healthy young adults, having no predisposing factors for S.
aureus infections; including recent hospitalizations, underlying medical issues or history
of S. aureus infection [Kobayashi and DeLeo, 2009]. These strains were highly virulent,
causing severe necrotic skin and soft tissue infections, and demonstrated an affinity for
individuals in highly populated or overcrowded areas, thereby contributing to increased
rates of transmission. These areas include places such as jails and military barracks
4

[Aiello et al., 2006; Pan et al., 2003]. Factors contributing to the pathogenic success of
CA-MRSA remain largely controversial and undefined; however two theories prevail
regarding the virulent phenotype associated with these strains. In a study by Li et al., [Li
et al., 2009], the virulent CA-MRSA phenotype was shown to be the result of
differentially expressed intrinsic elements, largely attributable to an overactive agr locus.
These findings differ from previous observations, in which acquired mobile genetic
elements were implicated in the hyper-virulent phenotype, largely mediated through the
pro-phage encoded Panton-Valentine leukocidin toxin (PVL), and the arginine catabolic
mobile element. These mobile genetic elements have been suggested to aid in the
increased rates of transmission observed in CA-MRSA strains, as well as immune
evasion strategies associated through the cytolytic activity of the PVL toxin [Deresinski,
2005; Diep et al., 2008; Li et al., 2009]. CA-MRSA strains, while highly virulent, remain
susceptible to many non β-lactam antibiotics [Chambers, 2001]. Treatment options are
however limited, particularly in light of reported CA-MRSA isolates with decreased
vancomycin susceptibility [Graber et al.].

Toxin Production in S. aureus. S. aureus is a highly ubiquitous organism that has been
implicated in a wide spectrum of diseases ranging from skin and soft tissue infections to
life threatening septicemia [Lowry, 1998]. These manifestations of disease are the result
of virulence factors expressed by the organism, and include toxins, hemolysins, and
proteases [Novick, 2006]. Typically, these are secreted factors which directly interact
with the host during infection, and facilitate invasion and colonization [Cheung et al.,
1992, 2008; Janzon et al., 1989; Peng et al., 1988]. The secretion of toxins in S. aureus is
5

controlled by global regulators that coordinate gene expression in a cell density and
growth phase dependent manner. This is achieved through the upregulation of factors for
invasion, adhesion and colonization, which facilitate the initial stages of infection. This
differs from cells approaching later growth phases, in which factors for invasion are
upregulated and those for colonization are down regulated. These later stages of growth
utilize exotoxins to spread throughout host tissues; achieved through the activities of
hemolysins, cytotoxins, proteases and leukocidins, etc. [Janzon et al., 1989; Novick, 2006,
1993; Peng et al., 1988].

Proteolytic Enzymes. Proteases function in a wide variety of essential regulatory and
housekeeping functions. Their importance is demonstrated by the observation that 2-3%
of the total gene products in all organisms are proteolytic enzymes [Rawlings et al., 2002].
Proteases are proteins that catalyze the cleavage of amide bonds in peptides via
exopeptidase or endopeptidase activity [Sarnovsky et al., 1929; Rawlings and Barrett,
1995]. Exopeptidases cleave peptide bonds proximal to the amino or carboxy terminus,
releasing free amino acids or small peptides [McDonald, 1986]. Endopeptidases cleave
internal peptide bonds, and release oligopeptides. Protein hydrolysis is further defined
according to the functional roles of active site residues [Taylor, 1993]. These functional
groups required for catalysis consist of serine, aspartic, cysteine, prolyl or metal cofactor
requiring metallo amino acid residues [Rawlings et al., 2002]. Serine proteases contain a
serine residue at their active site that covalently binds and processes substrates of broad
specificity [Rawlings and Barrett, 2004]. Aspartic proteases catalyze the hydrolysis of
peptide bonds from each end of aromatic or bulky amino acid residue containing
6

substrates. These proteases catalyzed acid-base reactions by virtue of two aspartic
residues located at their active site [Rawlings and Barrett, 1995]. Cysteine proteases
contain an active site cysteine residue, which requires a reducing agent for enzymatic
activity [Rawlings and Barrett, 2004]. Prolyl proteases are proline specific peptidases that
catalyze the cleavage of amide bonds following a proline residue or an imide bond that
precedes it. These proteases demonstrate full activity in the presence of manganese ions,
and maintain substantial sequence homology to various peptidases that require divalent
metal ions for catalysis [Bazan et al., 1994; Yaron and Naider, 1993]. Metalloproteases
require divalent metal ions at their active site to drive peptide hydrolysis, and are highly
diverse. These proteases are organized according to the conserved sequences that bind
metal ions at their active sites, often HEXXH [Bazan et al., 1994; Rawlings et al., 2002;
Taylor, 1993].

Proteases are further differentiated according to their cellular location, either
intracellularly, membrane/wall associated or secreted into the external environment. This
is largely dependent on the target substrates, enzymatic specificity and the fate of the
peptides released during hydrolysis. Generally, intracellular proteases function in
processes such as cell metabolism or sporulation [Dancer and Mandelstam, 1975;
Sussman and Gilvarg, 1971]. For example, the Lon and ATP-dependent proteases of
Escherichia coli regulate the destruction of damaged proteins in response to
environmental stress [Chung and Goldberg, 1981]. This type of response is necessary to
prevent the aggregation of hydrophobic residues that are exposed when proteins denature
due to heat or acid shock. Endopeptidase activities mediated by outer membrane
7

permeases provide the required transport of oligopeptides into the cell, once produced by
extracellular proteases. This activity is commonly vital for cell viability, and provides
exogenous sources of amino acids [Sussman and Gilvarg, 1971]. In addition to nutritional
roles, secreted proteases regulate protein maturation and activation events. This can be
achieved at the post translational level, when proteins are secreted in inactive zymogen
configurations [Drapeau et al., 1972; Rice et al., 2001; Schneewind et al., 1992; Shaw et
al., 2004]. One such example is seen in the programmed cell death and/or apoptosis of
eukaryotic cells. Apoptosis is mediated by caspase proteins that are synthesized and
secreted in an inactive form. To achieve a functional state, post translational proteolytic
processing must occur. This level of regulation ensures cell death signals are not
prematurely released [Kerr et al., 1972]. Further, the secreted protease of Pseudomonas
aeruginosa, elastase, has been implicated in the activation of host matrix
metalloproteases, and ultimate deregulation of host tissue destruction [Sorsa, 1992].
Membrane bound proteases serve an array of functions in the microbial cell, including
regulatory and nutritional roles, including the membrane bound protease of E. coli, RseP.
RseP functions in a two-step proteolytic cleavage process, known as regulated
intramembrane proteolysis, and assists in the induction process of σE under conditions of
stress, allowing for the rapid modification of gene transcription profiles [Akiyama et al.,
2004].

Proteases of S. aureus. The S. aureus genome encodes 132 putative proteases and 42
non-peptidase homologs [Merops]. Ten of the putative or characterized proteases are
secreted into the external environment in a temporally-regulated manner; V8 serine8

protease (SspA), staphophain A (ScpA), staphophain B (SspB), aureolysin (Aur), and the
serine-protease like enzymes (SplABCDEF) [Chan and Foster, 1998; Karlsson and
Arvidson, 2002; Rice et al., 2001; Shaw et al., 2004]. Many of these secreted proteases
have been characterized extensively and have been shown to contribute to the progression
of disease in S. aureus [Karlsson and Arvidson, 2002; Lindsay and Foster, 1999;
McAleese et al., 2001; McGavin et al., 1997]. The switch of infectious states from
adhesion to invasion has been suggested to be primarily driven by the interplay of these
secreted proteases, and cell adhesion and colonization factors [McGavin et al., 1997].
Indeed, multiple groups [Boles and Horswill, 2008; Beenken et al., 2010; Tsang et al.,
2008] identified this kind of modification of protein profiles during the detachment stages
of S. aureus biofilm. Specifically, an increase in the proteolytic activities of Aur and
SplABCDEF was observed during detachment, whereas adhesion proteins were down
regulated. These results are in accordance with the previously reported cleavage of an S.
aureus adhesion protein clumping factor B, ClfB, by Aur [McAleese et al., 2001].
Moreover, bacterial sepsis, aided by the cysteine proteases ScpA and SspB, was shown to
impact the severity and progression of infection and invasion [Imamura et al., 2005].

Aminopeptidases. Aminopeptidases are exopeptidases that liberate small peptides from
oligopeptides providing cellular sources of energy and nutrition [Christensen et al., 1999;
Li et al., 2009; Matsui et al., 2006]. This is typically achieved through the generation of
free amino acids, which are later catabolized for use as intermediates in central metabolic
pathways. Aminopeptidases are often substrate specific, and maintain conserved active
site residues and folding patterns. These specific properties enable the sub-categorization
9

of proteolytic enzymes into the following evolutionary based clans according to the
catalytic metals required for their active site residues, clans MF, MG, and MH, and are
explained in further detail below [Rawlings et al., 2002, Rawlings and Barrett, 2004;
Sussman and Gilvarg, 1971].

Metalloaminopeptidases. The metalloaminopeptidases are the largest and the most
homogenous aminopeptidase family. They are arranged into 25 families according to the
three conserved active site residues, histidine, glutamine, lysine and/or aspartate. These
families are further defined by evolutionary derived clans; MF, MG, and MH respectively
[Rawlings et al., 2002, Rawlings and Barrett, 2004]. Many of these peptidase families
require divalent metal ions at their active site to drive catalysis; most commonly zinc.
Metalloaminopeptidase clan MF is characterized by aminopeptidases that require two
zinc ions at their active site for catalysis, and includes the leucine aminopeptidase from
bovine lens [Kim and Lipscomb, 1993]. Clan MG metallopeptidases require either
divalent cobalt or manganese ions for activity. One such example of peptidases typified
by this clan is the highly conserved methionine aminopeptidases, which is required for
the maturation of newly synthesized proteins [Bazan et al., 1994; Ben-Bassat et al.,
1987]. The proteolytic enzymes characterized by clan MH represent a diverse mixture of
aminopeptidases, carboxypeptidases and dipeptidases, and typically require divalent zinc
ions at their active site, commonly aspartyl aminopeptidases [Russo and Baumann, 2004;
Franzetti et al., 2002].

10

Leucine Specific Aminopeptidases. The M17 family of the metallopeptidases clan MF
represents one of the most extensively studied classes of aminopeptidases. These are the
leucyl aminopeptidases, and require divalent zinc ions for catalysis [Kim and Lipscomb,
1993]. These peptidases have distinct active sites, with paired lysine and aspartic residues
for zinc ion binding, in addition to the catalytically active glutamic acid residues
[Rawlings and Barrett, 2004]. Leucine specific aminopeptidases drive hydrolysis of the
amide bonds from hydrophobic N-terminal amino acids, as well as di- and tripeptides.
The best studied of these aminopeptidases is that from bovine lens, which assembles into
a bilobal hexamer consisting of six 54 kDa subunits [Cuypers et al., 1982]. This structure
is maintained by hydrogen bonds and van der walls interactions, and inhibited by metal
chelating agents [Sussman and Gilvarg, 1971]. A homolog of the bovine leucine
aminopeptidase was identified in E. coli, and is termed aminopeptidase A or PepA
[Strater et al., 1999]. Protein sequence analysis reveals that PepA shares 31% amino acid
identity overall, and a 52% amino acid identity at the carboxy terminus, with the bovine
lens enzyme [Stirling et al., 1989]. E. coli aminopeptidase A is a multifunctional protease
with DNA-binding activities, regulated by three distinct promoters [Woolwine and
Wozniak, 1999]. It is catalytically activated in the presence of manganese and presumed
to function in peptide turnover and/or metabolism [Miller, 1996]. In addition, the DNAbinding activities of PepA are essential to ColE1 plasmid inheritance and Xer site
recombination [Cheung et al., 1992].

Aminopeptidases of S. aureus. Thirteen aminopeptidases are encoded in the genome of
S. aureus, many of which remain uncharacterized. These include aminopeptidases: pepA1,
11

pepA2, pepA3, pepF1, pepF2, pepM, pepP, pepQ, pepS, pepT1, pepT2, pepV and pepZ [Gill
et al., 2005; Sobral et al., 2007; Shaw unpublished observation]. The peptidases PepA1,
PepA2 and PepA3 are glutamyl serine aminopeptidases, all of which are approximately
350 amino acids in length. Aminopeptidase PepM is an essential methionine
aminopeptidase that modifies nascent polypeptides by removing the N-terminal
methionine upon ribosomal release [Chang et al., 1989]. Crystal structure analysis of
PepM performed by Oefner et al. [Oefner et al., 2003] reported the inhibition of this
essential aminopeptidase by 1, 2, 4-triazols, thus presenting a possible new target for
novel therapies against S. aureus. The catalytic and substrate processing activities of the
proline dipeptidases PepP and PepQ, and peptidase PepT1 have yet to be determined and
remain uncharacterized. Aminopeptidase PepS is an intracellular aminopeptidase, with a
substrate preference for the hydrophobic amino acid residues, Leu, Val, Phe, and Tyr.
The crystal structure analysis of PepS identified impaired catalytic activity in the
presence of the metal chelating agent EDTA, which was restored with the addition of
zinc or cobalt ions [Odintsov et al., 2005]. Additionally, analysis using antisense RNA
technology identified an impaired phenotype for growth in cells with reduced pepS
mRNA transcript levels [Yinduo et al., 2001]. PepV, a dipeptidase in S. aureus, has been
reported to vary among clonal variants of S. aureus, as peptidase activity was observed in
methicillin resistant strains only, and was absent in methicillin susceptible strains [Staub
and Sieber, 2009]. Additionally, the potential association for PepV and resistance in
MRSA strain has been suggested as a result of activity-based protein profiling
experiments, which identified the selective overexpression of dipeptidase activity in these
strains [Staub and Sieber, 2009]. Aminopeptidase PepZ is a putative cytosolic leucine
12

specific aminopeptidase based on sequence homology with a leucine aminopeptidase of E.
coli, PepA. A recent publication [Majerczyk et al., 2010] identified the decreased
expression of pepZ in a codY deficient S. aureus strain. In bacteria such as Lactococcus
lactis, CodY is a transcriptional regulator that senses available nutrients mediated through
interactions with branch chain amino acids, and often regulates aminopeptidases for
nutritional purposes accordingly [Majerczyk et al., 2010].

Aminopeptidases in Bacterial Pathogenesis. In addition to secreted toxins, there are a
number of components within bacterial genomes that do not directly participate in host
interactions, but still facilitate the infectious process. One such example is found within
the proteolytic activities of aminopeptidases. The role for intracellular bacterial
aminopeptidases in the aid and progression of disease remains largely uncharacterized;
however, secreted or surface exposed aminopeptidases have been associated with
virulence in some pathogens. In a study by Kumagai et al. [Kumagai et al., 1999], a
secreted dipeptidyl aminopeptidase (DPPIV) from Porphyromonas gingivalis was found
to be implicated in the formation of abscesses in mice. This was determined using a
model of wound formation, which identified decreased wound formation and mortality in
mice infected with aminopeptidase DPPIV deficient cells, compared to wild-type strain
infections [Kumagai et al., 1999]. A later report corroborated these findings, in which the
proteolytic activity of aminopeptidase DPPIV in P. gingivalis was shown to function in
the degradation of collagen in host tissues [Kumagai et al., 2005]. Further, a proteomic
analysis performed on membrane bound proteins from the zoonotic pathogen
Streptococcus suis revealed increased levels of two aminopeptidases in virulent strain
13

proteomes: a leucine aminopeptidase and aminopeptidase T. Moreover, the leucine
aminopeptidase

was

recently

determined

to

have

antigenic

properties

in

immunoreactivity assays [Wang et al., 2011]. This differential protein analysis performed
on proteomes from both virulent and avirulent strains of S. suis further substantiates the
potential of aminopeptidases as virulence factors in bacteria.
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Materials and Methods

Culture Media
All media was prepared using deionized water (diH2O) and was sterilized by autoclaving
at 121°C for 30 minutes unless otherwise indicated.

Tryptic soy broth (TSB)
3% tryptic soy

Luria-Bertani (LB) [Miller, 1972]
Tryptone

10 g L-1

Yeast

5 g L-1

NaCl

10 g L-1

Top agar
0.7% agar in TSB

Biofilm broth
3%

TSB

0.5% dextrose
3.0% NaCl
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B2
1%

casein acid

2.5% yeast
0.1% K2HPO4
2.5% NaCl

Chemically defined limiting media

Solution 1
L-Aspartic acid

3g

L-Alanine

2g

L-Arginine

2g

L-Cystiene

1g

Glycine

2g

L-Glutamic acid

3g

L-Histidine

2g

L-Isoleucine

3g

L-Lysine

2g

L-Leucine

3g

L-Methionine

2g

L-Phenylalanine

2g

L-Proline

3g

L-Serine

2g
16

L-Threonine

3g

L-Tryptophan

2g

L-Tyrosine

2g

L-Valine

3g

Na2HPO4

140 g

KH2PO4

60 g

diH2O

1400 ml

Solution 2
Biotin

0.4 mg

D-Pantothenic acid

8 mg

Pyridoxal

16 mg

Pyridoxamine diHCl

16 mg

Riboflavin

8 mg

Nicotinic acid

8 mg

Thiamine HCl

8 mg

diH2O

400 ml

Sterilize by filter sterilization.

Solution 3
Adenine sulphate

400 mg L-1

Guanine HCl

400 mg L-1
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HCl

0.1M

Solution 4
CaCl26H2O

1g

MnSO4

500 mg

Ferric Ammonium Sulphate

600 mg

HCl

0.1M

diH2O

100 ml

Solution 5
Glucose

100 g L-1

MgSO47H2O

5 g L-1

Amino acid limiting
Combine the following solutions and filter sterilize:
Solution 1

0.07%

Solution 2

0.02%

Solution 3

0.05%

Solution 4

0.001%

Solution 5

0.1%
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Glucose limiting
Prepare as indicated in the amino acid-limiting media protocol, with the exception of a
ten-fold reduction of glucose in solution 5.

Phosphate limiting
Prepare as indicated in the amino acid-limiting media protocol, with the exception of a
five-fold reduction of Na2HPO4 and KH2PO4 in solution 1.

Mannitol salt agar
Mannitol salt media was purchased from Fischer Scientific and prepared according to the
manufactures specifications.

Milk broth
Dried skim milk was reconstituted in diH2O at a 10% concentration and sterilized for 15
minutes by autoclaving

Purple broth
Purple both media was purchased from Fischer Scientific and prepared according to the
manufacture’s specifications.
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Buffers and Reagents

PBS
0.8%

sodium chloride

0.14%

disodium phosphate

0.02%

potassium chloride

0.02%

potassium dihydrogen phosphate

pH 7.4

Phage buffer
1M

MgSO4

4mM

CaCl2

5.9 g L-1

NaCl

1 g L-1

gelatin

50mM

Tris-HCl, pH 7.8

UDS buffer
6M

urea

5mM DTT
1%

SDS

50mM Tris-HCl, pH8
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2D-DIGE IEF buffer
7M

urea

2M

thiourea

4%

CHAPS

0.2% SDS
0.1M

DTT

10mM Tris-HCl, pH8.5

Laemmli buffer
diH2O

4.0 ml

0.5M Tris-HCl, pH6.8

1.0 ml

10% SDS

1.6 ml

100% glycerol

0.8 ml

β-Mercaptoethanol

0.4 ml

Bromophenol blue

0.05%

Stacking gel
diH2O

3.05 ml

10% SDS

50 µl

10% APS

25 µl

0.5M Tris-HCl, pH6.8

1.25 ml

TEMED

5 µl

Acrylamide

650 µl
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Separating gel
diH2O

3.35 ml

10% SDS

100 µl

10% APS

50 µl

1.5M Tris-HCl, pH8.8

2.5 ml

TEMED

7 µl

Acrylamide

4.0 ml

Destain solution
Methanol

10%

Acetic acid

5%

Coomassie blue stain
Methanol

50%

Acetic acid

10%

Coomassie blue

0.25%

10x electrophoresis buffer
Glycine

144 g L-1

Tris base

30.3 g L-1

SDS

10 g L-1
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Transfer buffer
Tris base, pH 8.5

5.8 g L-1

Glycine

2.9 g L-1

SDS

0.4 g L-1

Methanol

200 ml

TBST
25mM Tris, pH 7.6
0.05% Tween-20
0.15M NaCl

Blocking reagent
TBST

7.5 ml

10 mg ml-1 BSA or 10% milk

3 ml

HisProbe working solution
TSBT

10 ml

His-probe

2 µl

SuperSignal®West Pico Substrate
SuperSignal®West Pico Substrate was purchased from Pierce and prepared according to
the manufacture’s specifications.
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Bacterial Strains, Plasmids and Primers

Table 1. Bacterial Strains and Plasmids

*Cloning vectors pAZ106 and pMK4 where used for the molecular manipulation of bacterial strains
R

R

R

constructed in this study. Cm , chloramphenicol resistance; Ery , erythromycin resistance and Amp ,
ampicillin resistance.

Table 2. Primer Sequences

*Underlined sequences identify cloning restriction sites. Italicized sequences represent histidine tags added
for the construction of overexpression strains.

Transformations. All molecular manipulations were performed as described by
Sambrook and Russell [Sambrook et al., 2001].
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Electroporation of S. aureus. 20 ng of plasmid DNA was extracted and resuspended in
70 µl of competent RN4220 cells and transferred to a 1 mm gapped electroporation
cuvette. Electroporation was performed at room temperature using a BioRad Gene Pulser,
followed by cell recovery at 37°C shaking in 1 ml of B2 media for 90 minutes. Cells
were then plated onto TSA containing the correct antibiotic for selection, and incubated
overnight at 37°C.

Phage Transductions of S. aureus. Transductions were performed using overnight
bacterial cultures from transformants, combined with 1M CaCl2 and previously prepared
80α phage lysate, which were incubated at in a 37°C water bath for 20 minutes. The cells
were then recovered by centrifugation following the addition of 1% sodium citrate and
resuspension in TSB containing 0.5% sodium citrate. Cells were then incubated for one
hour in a 37°C water bath and centrifuged again prior to a second resuspension in TSB
containing 0.5% sodium citrate and plating onto selective media for overnight incubation
at 37°C [Mani et al., 1993].

Construction of a pepZ mutant. An S. aureus pepZ mutant was Available from
laboratory stocks, which was made as follows. A PCR fragment was cloned into the
vector pAZ106, which was purified and transformed into electrocompetent S. aureus
RN4220 cells. Clones were selected for based on the plasmid encoded erythromycin
resistance, and confirmed by PCR analysis. A representative clone was used to generate
an 80α phage lysate for the transduction of S. aureus SH1000, Newman and USA300
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FPR. Clones were then again selected for according to the erythromycin cassette and
confirmed by PCR analysis.

Construction of pepZ-lacZ Reporter Gene Fusions. The reporter fusions were
constructed from a 1211 bp fragment, which was PCR amplified using forward primer
895 located 626 bp upstream from the pepZ start codon and reverse primer 462 located
544 bp downstream of the start codon (Table 2). This fragment was then cloned into the
suicide vector pAZ106, which contains a promoterless lacZ cassette located downstream
of the multiple cloning site, for the construction of transcriptional fusions. Once this
construct was confirmed in E. coli, purified plasmid was electroporated into the S. aureus
strain RN4220 and a prepared lysate was then transduced into the wild-type strains
SH1000, USA300 FPR and Newman for characterization experiments [Mani et al., 1993;
Sambrook et al., 2001; Schenk and Laddaga, 1992].

Transcriptional Analysis

Transcriptional Analysis of pepZ Expression. Exponentially growing pepZ-lacZ
reporter fusion cells were standardized to an OD600 of 0.05 in TSB and returned to 37°C
shaking. Optical density measurements and 1 ml sample collections were obtained hourly
for eight hours, with a final measurement and collection at 24 hours. A standard βgalactosidase assay was then performed from duplicate samples to determine the
expression profile of pepZ under standard conditions and values averaged [Sambrook et
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al., 2001]. One unit of β-galactosidase activity was defined as the amount of enzyme that
catalyzed the production of 1 pmol MU min-1 OD600 unit-1.

Transcriptional Disk Diffusion Assays. Sterile filter disks (7 mm, 3MM Whatman
Paper) were placed onto of a TSA plate overlayed with TSA top agar (0.7% w/v),
containing pepZ-lacZ reporter strain fusion cells and 40 µg ml-1 X-GAL [Cao et al.,
2002]. Chemical stressors were then applied to the filter disks in volumes of 10 µl and
incubated overnight at 37°C (hydrochloric acid, phosphoric acid, trichloroacetic acid,
formic acid, acetic acid, sulfuric acid, nitric acid, sodium hydroxide, sodium chloride,
glucose, ethanol, methanol, isopropanol, SDS, Triton X-100, Tween-20, N-lauroyl
sarcosine,

hydrogen

peroxide,

menadione,

pyrogall,

sodium

nitroprusside,

4-

methylmethanesulfonate, penicillin-G, vancomycin, phosphomycin, spectinomycin,
ampicillin, tetracycline, erythromycin, lincomycin, kanamycin, neomycin, rifampicin,
chloramphenicol, puromycin, oxacillin, bacitracin, mupirocin, diamide, berberine Cl,
peracetic acid, EDTA, DTT and triclosan). The upregulation of pepZ expression was
determined by screening for blue color changes in the media [Sambrook et al., 2001].

Growth and Nutrition Profiling

Growth Analysis in Peptide Based Media. Bacterial cells were grown to exponential
phase at 37°C while shaking, washed in PBS and resuspended in 10% autoclaved milk to
an OD600 of 0.05. Viable cell counts were performed in PBS every hour for 30 hours by
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serial plating onto TSA. Plates were incubated overnight at 37°C and measured the
following day by exact colony counts to determine CFU ml-1.

Long-Term Starvation Analysis. Starvation analysis was examined from three
independent cultures prepared using exponentially growing cells, which were washed in
PBS and resuspended in 10% autoclaved milk or sterile TSB to an OD600 of 0.05.
Cultures were grown shaking or static at 37°C and monitored by viable cell counts
performed daily for seven days (shaking and static) cultures or weekly for four weeks
(static cultures). Data was analyzed using a Student’s t test with a 5% confidence limit to
determine statistical significance

Competitive Growth Analysis. Competitive growth analysis was performed by
inoculating sterile 10% reconstituted dried skim milk and TSB with exponentially
growing wild-type and pepZ mutant cells in a 1:1 ratio, following PBS washes.
Cocultures were grown shaking or static at 37°C and monitored by viable cell counts
performed daily for seven days (shaking and static cultures) or weekly for four weeks
(static cultures). Viable cell counts were performed by serial plating onto both TSA, and
TSA containing erythromycin, which were incubated overnight at 37°C. The exact
enumeration of both viable wild-type and pepZ mutant cells was used to calculate the
competitive index (CI) [Shaw et al., 2008]. Data was analyzed using a Student’s t test
with a 5% confidence limit to determine statistical significance.
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Proteomic Analysis

Cytoplasmic Protein Extraction. Synchronized cultures were harvested from cultures
grown continuously while shaking at 37°C, hours 1 through 8 and 15. Cultures were
centrifuged for ten minutes at 4150 RPM and the resulting pellet was washed three times
in PBS. The final pellet was resuspended in either 750 µl UDS buffer for subcellular
localization profiling or 200 µl of IEF buffer for 2D-DIGE. Cells were then lysed using a
BioSpec Mini-BeadBeater, with 0.1 mm glass disruption beads for a total of four minutes
in one minute intervals. Lysed cells were then centrifuged at 4°C for ten minutes at
13,300 RPM and the protein fractions were transferred into new tubes and measured for
protein concentration using a Pierce 660 nm protein assay kit.

Secreted Protein Extraction. Proteins were harvested from synchronized cultures grown
continuously at 37°C shaking at hours: 1 through 8 and 15. Cultures were centrifuged for
ten minutes at 4150 RPM and the remaining supernatants were filter sterilized to remove
residual whole bacterial cells. Supernatants were then precipitated at final concentrations
of 10% trichloroacetic acid overnight at 4°C. The following day, precipitated secreted
proteins were centrifuged for ten minutes at 4150 RPM at 4°C and washed with 100% ice
cold ethanol three times. Protein pellets were then air dried and resuspended in either 750
µl UDS buffer for subcellular localization profiling or 200 µl of IEF buffer for 2D-DIGE,
and measured for protein concentration using a Pierce 660 nm protein assay kit.
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Western Blot Detection. Western blot detection of pepZ 6-His tagged proteins was
performed using a Pierce PVDF Transfer Membrane and SuperSignal West HisProbe Kit.
Intracellular and secreted proteins were extracted at various time points from cultures
containing standardized pMK4::pepZ 6-His tagged cells. As a negative control, proteins
were extracted from cells containing the pMK4 vector only, concurrently. Protein
concentrations were quantified and then resolved using SDS-PAGE and transferred onto
a polyvinylidene diflouride membrane. Following protein transfer, the membrane was
blocked for one hour at room temperature or overnight at 4°C, washed in TBST, and
probed for 6-His tagged proteins. Chemoluminescent substrate detection was then
performed using horse radish peroxidase and hydrogen peroxide in equal volumes and
proteins were visualized by X-ray detection.

2D Difference Gel Electrophoresis (DIGE). Intracellular and secreted protein fractions
were extracted from continuously grown USA300 FPR wild-type and pepZ mutant strain
cultures after three hours and prepared as previously described. The purified protein
fractions were then transferred to the ICBR facility at the University of Florida for 2DDIGE CyDyeTM analysis. 50 ug of protein from the pepZ mutant and wild-type samples,
and internal standard were labeled with either, Cy5, Cy2 and Cy3 CyeDyeTM, and
separated based on charge using two dimensional isoelectric focusing. The proteins were
then further separated by molecular weight using SDS-PAGE. This was followed by the
in-gel analysis of wild-type and pepZ mutant labeled samples using a Typhoon 9600
Variable Mode Imager. Changes in protein abundance were determined by DeCyderTM
v.7.0 Differential Analysis Software and then extracted by ProPicTM. The extracted
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proteins were then digested with trypsin and analyzed for identification using mass
spectrometry and MASCOT software.

Trypsin Digestion. Trypsin digestion was performed using 100 µg of standardized
protein. Protein samples were reduced at room temperature for one hour using 50 µl of
200mM dithiothreitol (DTT). Alkylation was then performed for one hour in the dark
using 200 µl of 200mM iodoacetamide (IAA). An additional 200 µl of 200mM DTT was
added to the samples to consume residual IAA. The samples were then diluted with
25mM ammonium bicarbonate to 5 ml, and digested with trypsin in a ratio of 1: 30 of
trypsin weight to protein for 16 hours at 37˚C, and desalted the following day.

Desalt. Peptide desalting was performed using C-18 Vydac columns. The columns were
activated with the addition of 1 ml of 100% acetonitrile, and repeated once. Column
equilibration was carried out by applying 1 ml of 0.1% formic acid in diH2O to the
columns, and repeated once. The peptides were then applied to the columns and washed
two times with 1 ml of 0.1% formic acid in diH 2O. Peptides were then eluted from the
columns using 300 µl of 0.1% formic acid in acetonitrile, and repeated two times. The
peptide samples were dried using SpeedVac centrifugation and resuspended in 100 µl of
0.1% formic acid in diH2O. Peptides were further prepared by sonication for ten minutes
and then analyzed using mass spectrometry.
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Virulence Assays

Murine Model of Septic Arthritis. Female NRMI mice, 6 to 8 weeks old were
inoculated intravenously with either 1 x 107 Newman wild-type or Newman pepZ mutant
bacterial cells via tail vein injection, and evaluated for 12 days for the progression and
severity of infection. Following animal sacrifice, septic dissemination and persistence
was quantified as CFU ml-1 from kidney cellular homogenates harvested twelve days post
inoculation, which were serial diluted in PBS and plated on horse blood agar plates and
incubated for 24 hours. Clinical arthritic index measurements ranging from 0 to 3 were
used to define the severity of erythema and/or swelling of at least one joint resulting from
systemic infections using a double blind method. Each mouse limb was evaluated and
scored for septic arthritis severity according to the following criteria: 1, mild swelling
and/or erythema; 2, moderate swelling and erythema; 3, marked swelling and erythema.
The sum of these scores corresponds to an arthritic index value used to quantify the
severity of arthritis for each animal [Calander et al., 2004; Shaw et al., 2008].

Biofilm Formation Analysis. Biofilm formation was examined in triplicate from
bacterial cells grown overnight in sterile biofilm media. The following day, 200 µl of
culture was resuspended in sterile biofilm media to an OD600 of 0.1 and used to inoculate
wells of a 96 well microtiter plate previously overlain with 20% human plasma. The
microtiter plate was then incubated overnight at 37°C, before the culture was carefully
removed and washed three times with PBS and allowed to air dry the following day. The
biofilms were then fixed with 100% ethanol, air dried, stained with 10% crystal violet
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and washed with PBS again. The plate was dried overnight at room temperature, and with
the addition and removal of 100% ethanol, biofilm formation was measured via
absorbance readings at 610 nm using a microtiter plate reader the following day
[Beenken et al., 2003].

Human Macrophage Survival and Clearance. A human model of macrophage survival
and clearance was performed in two independent experiments using Newman wild-type
or pepZ mutant cells to inoculate wells of a microtiter plate containing human
macrophages, in a ratio of 1: 50. Cell viability per well was monitored by quantitative
plating at hours 0, 2, 24, 48, 72 and 96 post-inoculum [Koziel et al., 2009].

Murine Model of Wound Formation. Ten hairless, SKH-1 immunocompetent mice
were inoculated subcutaneously in the right flank with 1.00 x 108 USA300 FPR wild-type
or pepZ mutant cells for each strain. Infection was monitored for seven days and any
abscesses formed were harvested following animal euthanasia [Bunce et al., 1992; Chan
and Foster, 1998]. Viable S. aureus cells were quantified by serial diluting harvested
abscess homogenates in PBS, and plating onto TSA. Plates were incubated overnight at
37°C, and CFU per abscess and percent recovery was determined the following day by
colony enumeration. Data was analyzed using a Student’s t test with a 5% confidence
limit to determine statistical significance.

Murine Model of Bacterial Sepsis. Twenty female six-week old CD-1 Swiss, outbred
and immunocompetent mice (Charles River Laboratories) were inoculated via tail vein
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injection with 100 µl of 1.00 x 108 CFU ml-1 USA300 FPR wild-type or pepZ mutant cells
in PBS for each strain. Mouse survival was monitored daily for seven days.

Phenotypic Characterization

Growth Profiling using Chemically Defined Media. Agar plates (amino acid limiting,
mannitol salt agar, and phosphate limiting) were inoculated using three single wild-type
or pepZ mutant colonies, and grown in parallel, aerobically and anaerobically overnight
at 37°C. The following day, changes in growth patterns were observed for the various
conditions.

Evaluating Carbon Utilization. Carbon utilization was explored in triplicate using 5 µl
of standardized bacterial culture to inoculate wells of a microtiterplate containing 250 µl
of sterile purple broth enriched with 2.5 µg ml-1 of; galactose, ribose, lactose, mannose,
fructose, trehalose, raffinose, D-glucosamine or xylose. The plate was covered and
incubated overnight at 37°C, and the following day, color changes from purple to yellow
were used to determine utilization of the carbon sources.

Lysis Kinetics. Conditions of cell lysis were explored using exponentially growing
bacterial cells washed in PBS, and resuspended to an OD600 of 2.0, in either sterile TSB
containing 0.4 ug ml-1 penicillin-G or 0.05M Tris-HCl (pH7.6) containing 0.05% TritonX-100. Cell lysis was measured by changes in turbidity every 30 minutes [Fujimoto and
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Bayles, 1998; Mani et al., 1993; Shaw et al., 2005]. Data was analyzed using a Student’s t
test with a 5% confidence limit to determine statistical significance.

Heat Shock. Exponentially growing bacterial cells were resuspended in sterile TSB to
OD600 of 0.2. Heat shock was induced by placing cultures in a 55°C water bath for 30
minutes, which were promptly returned to standard growth conditions at 37°C shaking.
Cell viability was monitored in 30 minute intervals by optical density readings at OD 600
[Shaw et al., 2008].

Heat Stress. Exponentially growing bacterial cells were resuspended in sterile TSB to
OD600 of 0.05. Bacterial cells were assayed for adaptation to heat stress at 55°C shaking,
which was measured by viable cell counts performed every 20 minutes for two hours.
Serial diluted TSA plates were incubated at 37°C overnight and observed for CFU ml-1
percent survival the following day [Shaw et al., 2008]. Data was analyzed using a
Student’s t test with a 5% confidence limit to determine statistical significance.

Oxidative Stress. Exponentially growing bacterial cells were washed and resuspended in
sterile PBS containing 7.5mM hydrogen peroxide. Cultures were incubated while shaking
at 37°C and monitored in 20 minute intervals by viable cell counts diluted in PBS
containing 10 mg-1 catalase, for hydrogen peroxide inactivation. Serial diluted plates
were incubated at 37°C overnight and observed for CFU ml-1 percent survival the
following day [Watson et al., 1998].
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Disk Diffusions. General stress profiling was investigated using a modified Kirby-Bauer
Assay performed in triplicate. As described previously, sterile filter disks (7 mm, 3MM
Whatman Paper) were placed onto of a TSA plate overlayed with TSA top agar (0.7%
w/v), containing wild-type or pepZ mutant strain cells [Cao et al., 2002]. Chemical
stressors were then applied to the filter disks in volumes of 10 µl and incubated overnight
at 37°C without the addition of X-GAL [Shaw et al., 2008]. Zones of inhibition were
measured to identify changes in susceptibility to the various chemical compounds:
hydrochloric acid, phosphoric acid, trichloroacetic acid, formic acid, acetic acid, sulfuric
acid, nitric acid,

sodium hydroxide, sodium chloride, glucose, ethanol, methanol,

isopropanol, SDS, Triton X-100, Tween-20, N-lauroyl sarcosine, hydrogen peroxide,
menadione, pyrogall, sodium nitroprusside, 4-methylmethanesulfonate, penicillin-G,
vancomycin, phosphomycin, spectinomycin, ampicillin, tetracycline, erythromycin,
lincomycin, kanamycin, neomycin, rifampicin, chloramphenicol, puromycin, oxacillin,
bacitracin, mupirocin, diamide, berberine Cl, peracetic acid, EDTA, DTT and triclosan.
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Results

Analysis of the Virulence of a S. aureus pepZ mutant using a Murine Model of Septic
Arthritis. During a previous screen in our laboratory focused on the role of proteases in
S. aureus virulence, we identified a mutant in aminopeptidase Z as being attenuated in
disease causation. Specifically, the role of PepZ in S. aureus virulence was examined
using a murine model of septic arthritis, in collaboration with Dr. Andrej Tarkowski from
the University of Goteborg, Sweden. Female NRMI mice, 6 to 8 weeks old were
inoculated intravenously with either the Newman wild-type or Newman pepZ mutant
strain, and evaluated over twelve days for the progression and severity of infection. Mice
infected with pepZ mutant cells displayed markedly reduced levels of septic
dissemination, weight loss, and severity of infection. Septic dissemination and
persistence within the host was quantified as CFU ml-1 from kidney cellular
homogenates, harvested twelve days post inoculation. Dissemination of the pepZ mutant
was severely attenuated compared to the wild-type (Fig. 1A), with an approximate one
log reduction of mutant cells recovered from the kidneys of infected mice. In addition,
infection associated weight loss was strikingly reduced in the pepZ mutant (Fig. 1B).
Twelve days post inoculation, mice infected with pepZ mutant cells averaged a decline in
weight of 10%, varying considerably from the average 27% weight loss in wild-type
infections. Clinical arthritic index measurements ranging from 0 to 3 were used to define
the severity of erythema and/or swelling of at least one joint resulting from systemic
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infection. Each mouse limb was evaluated and scored for septic arthritis severity
according to the following criteria: 1, mild swelling and/or erythema; 2, moderate
swelling and erythema; 3, marked swelling and erythema. The sum of these scores
corresponds to an arthritic index value used to quantify the severity of septic arthritis for
each animal [Calander et al., 2004]. Symptoms of clinical arthritis measured at five and
twelve days post infection showed significant reductions in pepZ mutant strain infections
(Fig. 1C). Histological evaluation of athritic synovitis and erosion of bone and cartilage
showed decreases in serverity in mutant strain infections as well (Fig. 1D).

Figure 1. Characterization of the Role of PepZ in Systemic Dissemination using a Murine Model of
Septic Arthritis. S. aureus strain Newman and its pepZ mutant were injected into 10 mice per strain and
evaluated for 12 days to identify variations in pathogenesis. (A) Septic dissemination to the kidneys
represented as CFU/ml. (B) Weight loss over 12 days (C) Arthritic index measurements 5 and 12 days post
inoculation. (D) Histological index.
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Profiling pepZ Expression using a lacZ Reporter Fusion. Given the obvious
importance of aminopeptidase Z in S. aureus infection, we set out to characterize pepZ
expression to further understand the way in which the cell employs this enzyme. This was
achieved using pepZ-lacZ reporter fusion strains. These were constructed from a 1211 bp
fragment, which was PCR amplified using a forward primer located 626 bp upstream
from the pepZ start codon and a reverse primer located 544 bp downstream of the start
codon. This fragment was then cloned into the suicide vector pAZ106, which contains a
promoterless lacZ cassette located downstream of a multiple cloning site, for the
construction of transcriptional fusions (Fig. 2).

Figure. 2. Physical Map of the Plasmid pAZ106 used to construct pepZ-lacZ Reporter Gene Fusions
in S. aureus. Restriction sites within the multiple cloning site upstream of the lacZ gene are shown on the
map. The pepZ promoter fragment was inserted at the XbaI and BamHI restriction sites, in which the
promoter region is indicated by a blue arrow. The pAZ106 vector contains ampicillin and erythromycin
antibiotic resistance genes for selection in E. coli and S. aureus, respectively, as shown.
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This construct was confirmed in E. coli, with purified plasmid then being electroporated
into the S. aureus strain RN4220. Clones were selected via the erythromycin resistance
cassette, and confirmed by PCR using forward primer 895 located 626 bp upstream from
the pepZ start codon and reverse primer 761 located at 7458 bp on the suicide vector
pAZ106 (Table 2). A confirmed clone was then used to generate an 80α phage lysate, for
the transduction of the wild-type S. aureus strains SH1000, USA300 FPR and Newman.
These pepZ-lacZ reporter fusion strains were again, selected for based on erythromycin
resistance and confirm by PCR. The activity of the pepZ promoter was quantified using
fluorescent light absorbance assays, which were achieved using 4-MUG as a substrate for
β-galactosidase activity. We determined maximal levels of pepZ expression are achieved
consistently during exponential growth (2-3h) in all backgrounds tested (Fig. 3).

Figure 3. Transcriptional Analysis of pepZ Expression in Liquid Media. Expression analysis using
pepZ-lacZ fusion strains grown in TSB, in SH1000 (◆), Newman (X) and USA300 FPR (●). Maximal
expression of pepZ occurs consistently during exponential growth (2-3h), regardless of the strain tested.
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Evaluating the Effects of Environmental Stimuli of pepZ Transcription. To further
characterize the transcriptional regulation of pepZ, we employed transcriptional disk
diffusion assays. This allowed us to identify changes in pepZ expression in response to a
variety of chemical stressor compounds (Table 3). This was performed using pepZ-lacZ
fusion strains in the SH1000, USA300 FPR and Newman backgrounds. Briefly, sterile
filter disks (7 mm, 3M Whatman Paper) were placed on a TSA plate previously
overlayed with TSA top agar (0.7%), containing 4 µg ml-1 X-GAL, and reporter fusion
cells grown overnight, and diluted 1: 1000 [Cao et al., 2002]. Chemical stressors were
then applied to the filter disks in a volume of 10 µl, and incubated overnight at 37°C. The
upregulation of pepZ expression was determined by screening for blue color changes in
the media, resulting from the cleavage of X-Gal by β-galactosidase [Sambrook et al.,
2001]. This method of analysis identified the induction of pepZ in response to oxidative
stress, cell wall perturbation and protein synthesis disruption. Specifically, the Newman
pepZ-lacZ strain demonstrated pepZ expression in response to: hydrogen peroxide,
oxacillin, rifampicin and bacitracin. Similar results were observed from the SH1000
pepZ-lacZ fusion strain, in which hydrogen peroxide, oxacillin, rifampicin, bacitracin,
penicillin-G, peracetic acid and N-lauroyl sarcosine upregulated pepZ expression. The
upregulation of pepZ in response to sulfuric acid, Triton X-100, N-lauroyl sarcosine,
hydrogen peroxide, vancomycin, ampicillin, oxacillin, triclosan and bacitracin was
identified in the USA300 FPR reporter fusion strain (Table 4).
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Table 3. Chemical Stress List
Stress

Agent

Concentration

Acid

HCl
Phosphoric Acid
TCA
Formic Acid
Acetic Acid
Sulphuric Acid
Nitric Acid

1M
85%
100%
88%
12M
12M
12M

Alkaline

Sodium Hydroxide

3M

Osmotic

NaCl
Glucose

1M
1M

Alcohol

Ethanol
Methanol
Isopropanol

100%
100%
100%

Detergent

SDS
Triton X-100
Tween-20
N-lauroyl sarcosine

10%
1%
1%

Oxidative

Hydrogen peroxide
Menadione
Pyrogall

30%
1%
400 mg/ml

Nitrostative

Sodium Nitroprusside

2.5M

DNA Damaging

4-methyl methanesulfonate

1M

Antibiotic

Penicillin-G
Vancomycin
Phosphomycin
Spectinomycin
Ampicillin
Tetracycline
Erythromycin
Lincomycin
Kanamycin
Neomycin
Rifampicin
Chloramphenicol
Puromycin
Oxacillin
Bacitracin
Mupirocin

2 mg/ml
2 mg/ml
2 mg/ml
5 mg/ml
100 mg/ml
5 mg/ml
5 mg/ml
5 mg/ml
50 mg/ml
50 mg/ml
5 mg/ml
10 mg/ml
20 mg/ml
5 mg/ml
5 mg/ml
2 mg/ml

Disulfide

Diamide

500mM

Misc.

Berberine Cl
Peracetic Acid
EDTA
DTT
Triclosan

12.8 mg/ml
4.2M
0.1M
1mM
10%

*Stressor compounds used for general stress profiling of pepZ mutant strains, and transcriptional profiling
for the activity of the pepZ promoter using reporter fusion strains.
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Table 4. Stressor Compounds Identified to Induce pepZ Transcription

*Transcriptional disk diffusion assays using pepZ-lacZ reporter fusion strains were performed in triplicate
and identified compounds associated with oxidative stress and cell wall synthesis disruption induced pepZ
expression.

Investigation of the Role of PepZ during S. aureus Growth in Peptide Rich Media.
Aminopeptidases commonly have a role in cellular nutrition, resulting from their
cleavage of imported oligopeptides [Linderstrom-Lang, 1929; McDonald, 1986;
Rawlings and Barrett, 2004]. The resulting free amino acids can then be utilized as
intermediates in central metabolic pathways required for continued cell growth and
propagation [Sussman and Gilvarg, 1971]. Accordingly, the potential role of PepZ in S.
aureus nutrition was explored in peptide based media (dried skimmed milk) using wildtype strains USA300 FPR and Newman, and their pepZ mutant derivatives. Dried
skimmed milk contains limited free amino acids, and abundant amounts of casein, a milk
protein cleaved by aminopeptidases in other bacterial species. As such, strains deficient
in aminopeptidases, such as PepZ, might perhaps be expected to have a reduced capacity
for nutrient acquisition when grown under such conditions, resulting in decreased
survival and viability. Experiments were performed with Newman and USA300 FPR
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wild-types and pepZ mutant strains grown continuously in 10% milk for 30 hours, with
shaking at 37°C. Cell viability was measured hourly and quantified by viable cell counts,
plated in duplicate. In this experiment we identified similar peptide utilization profiles
across all strains assayed (Fig. 4). Interestingly, at later time points, both the Newman
wild-type and Newman pepZ mutant cells were identified to reach higher population
densities when compared to USA300 FPR wild-type and USA300 FPR pepZ mutant
cells. Specifically, the USA300 FPR wild-type and pepZ mutant strains both achieved an
approximately 5-fold increase in cell density after 30 hours of continuous growth in milk
media, when compared to their starting inocula. Viable cell counts from the Newman
lineage strains, however, revealed a 28-fold increase from the initial inoculum of the
parent, and a similar 29-fold increase for the mutant. These results suggest that Newman
lineage strains are perhaps better adapted for growth in peptide rich environments than
USA300 FPR strains; and that, more generally, PepZ is dispensable for growth in media
where peptides form the sole carbon and nitrogen source.
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Figure 4. Analysis of Growth in Peptide Based Media. Growth analysis was performed over thirty hours
in sterile 10% reconstituted milk media and monitored by duplicate CFU mlˉ¹ plating hourly in strains:
USA300 FPR (X), USA300 FPR pepZ (■), Newman (●) and Newman pepZ (◆). In this experiment we
identified similar peptide utilization profiles across all strains assayed. Data is expressed as CFU mlˉ¹
averages from serial plating at the indicated time intervals.

Investigating the Role of PepZ during Long-Term Starvation. The potential role for
PepZ in long-term starvation survival was then explored using milk media and TSB,
under both static and shaking conditions at 37°C. TSB is a complex medium containing
abundant free amino acids, as well as carbon sources; differing significantly in
composition from the peptide-rich milk media. Starvation analysis was examined from
three independent cultures of TSB or milk containing exponentially growing Newman,
USA300 FPR, Newman pepZ or USA300 FPR pepZ mutant cells. Cultures were grown
shaking or static at 37°C and monitored by viable cell counts performed daily for seven
days (shaking and static cultures) or weekly for four weeks (static cultures only). Shaking
and static growth conditions were both used for analysis to determine changes in cell
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viability while limited for oxygen in static culture, or in environments rich in oxygen, in
shaking cultures. Cultures grown aerobically in TSB for one week resulted in similar cell
death patterns across all strains tested (data not shown). Viable cell counts showed peak
cell densities were achieved at day one, and steadily declined through day seven of the
experiment. These results differ from TSB cultures grown under static conditions.
Newman strains grown statically in TSB showed no distinct alterations between mutant
and wild-type following one week of growth. At two weeks of static growth, we
identified a 5% cell survival for the Newman pepZ mutant cells and a 24% cell survival
for the Newman wild-type cells (Fig. 5A). At three weeks of starvation, a 15% cell
survival for the Newman wild-type cells was determined; corresponding to an increase of
4.59-fold in growth when compared to the 7% survival of the mutant. Even larger
variations were observed at four weeks of starvation, in which the 12% Newman wildtype cell survival measured 4-fold greater than that of the 3% cell survival identified for
the mutant. Interestingly, viable cell counts from USA300 FPR wild-type and pepZ
mutant cells grown statically in TSB identified a consistently larger viable cell population
in pepZ mutant cells, compared to the wild-type (Fig. 5B). The USA300 FPR pepZ
mutant was determined to remain at viable cell densities approximately 2.45-fold greater
than the wild-type throughout the first three weeks of the experiment, which decreased to
1.75 after four weeks. The USA300 FPR wild-type cells resulted in cell survivals of 11%
at one week of growth, 7% at two weeks of growth, 5% at three weeks of growth and 4%
following four weeks of growth. In comparison, USA300 FPR pepZ mutant cell survival
was determined to be 27% after one week of growth, 18% at two weeks of growth, 12%
at three weeks of growth and 7% following four weeks of static growth in TSB.
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Figure 5. Long-Term Starvation Response of pepZ mutants Grown in TSB. (A) Newman wild-type (●)
and pepZ mutant (■), and (B) USA300 FPR wild-type (●) and pepZ mutant (■) cells were grown
statically in complex media at 37˚C. Viable cell counts were measured weekly at the specified time
intervals. At four weeks of static starvation Newman wild-type cell survival measured 4-fold greater than
that of the mutant. Viable cell counts from the USA300 cultures identified a consistently larger viable cell
population in pepZ mutant cells, compared to the wild-type. Data is represented as percent survival from
the inoculum from 3 independent experiments (+/- SD). Significant values (*) were determined using a
Student’s t test (p<0.05).

Starvation experiments performed in peptide based media for one week identified
decreased survival of Newman pepZ mutant cells when cultured in static or shaking milk
media, when compared to the parent. Static starvation assays performed in milk media
revealed wild-type cell recovery was 3.7-fold greater than the mutant at day five, and 4fold larger at day six (Fig. 6A). At seven days post inoculation we determined viable cell
densities of 118% for Newman wild-type cells and 65% for pepZ mutant cells,
representing a 1.8-fold change. The percent recovery for aerated milk cultures seven days
post inoculation was determined to be 18% for Newman wild-type cells and 7% for
Newman pepZ mutant cells, representing an approximately 4.5-fold change. Similar fold
changes were observed between these two strains between days 3-6 (Fig. 6B). Starvation
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analysis of USA300 FPR wild-type and pepZ mutant strains cultured in static peptide
based media failed to identify any changes in cell fitness or survival, suggesting no
apparent role for PepZ under these conditions (data not shown). In contrast, phenotypic
variations were identified between the two USA300 FPR strains when cultured in peptide
based media with shaking (Fig. 7). USA300 FPR pepZ mutant cells demonstrated an
impaired cell survival of approximately 6.41-fold when compared to wild-type cells after
only four days of growth under these conditions. The percent survival of viable cells
remaining in cultures after seven days was determined to be 37% for wild-type cells and
5% for pepZ mutant cell cultures, representing an almost 8.9-fold change.

Analysis of pepZ mutants during long-term starvation was carried out for four weeks, and
failed to provide any additional insights beyond the seven day starvation experiments
(data not shown). This suggests that the aminopeptidase activity of PepZ is most
important during initial periods of long-term starvation.
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Figure 6. Starvation Response of Newman pepZ mutants Grown in Peptide Based Media. Newman
wild-type (●) and pepZ mutant (■) strains grown (A) statically in 10% milk media at 37˚C or (B) in milk
media with shaking at 37°C. At seven days of growth, static milk cultures demonstrated a 1.8-fold change
in cell viabilities between mutant and wild-type, whereas aerated cultures identified a 4.5-fold change
between the two strains. Data is represented as an average percent survival of the inoculum from 3
independent experiments (+/- SD). Significant values (*) were determined using a Student’s t test (p<0.05).

Figure 7. Starvation Response of CA-MRSA pepZ mutants in Peptide Based Media. USA300 FPR
wild-type (●) and pepZ mutant (■) cells were grown in 10% milk media at 37°C with shaking. Viable cell
counts were measured daily at the specified time intervals and the pepZ mutant cells demonstrated an
impaired cell survival of approximately 6.41-fold when compared to wild-type cells consistently observed
after only four days of growth. Data is represented as average percent survival of the inoculum from 3
independent experiments (+/- SD). Significant values (*) were determined using a Student’s t test (p<0.05).
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Competitive Growth Analysis Reveals pepZ mutants are Impaired in their Ability to
Compete with Wild-Type Strains. In order to further explore the hypothesis that the
aminopeptidase activity of PepZ is important for nutrient acquisition in S. aureus we next
performed coculture experiments in either TSB or 10% milk media. These were
inoculated in a 1:1 ratio with either exponentially growing Newman wild-type and
Newman pepZ mutant cells, or with USA300 FPR wild-type and USA300 FPR pepZ
mutant cells. Cocultures were grown at 37°C and monitored by viable cell counts
performed daily for seven days (shaking and static cultures) or weekly for four weeks
(static cultures). Viable cell counts were performed by serial plating onto both TSA, and
TSA containing erythromycin. In doing so, the exact enumeration of both viable wildtype and pepZ mutant cells was obtained to determine the competitive index (CI). This
was achieved via the erythromycin resistance cassette carried on the pAZ106 plasmid
used to generate the pepZ mutant strains, creating a method for selection of pepZ mutant
cells only [Shaw et al., 2008].

From these experiments, we derived significant impairment in the ability of pepZ mutant
strains to compete for nutrients while in coculture with S. aureus wild-types. This
phenotype was observed in both backgrounds when cultured either static or shaking in
peptide based media or TSB. Newman wild-type strains inoculated with its pepZ mutant
in a 1:1 ratio in 10% milk media resulted in a 1: 0.37 ratio after 24 hours of static growth,
which declined further to 1: 0.14 after 48 hours, 1: 0.011 days 5-6 and 1: 0.009 following
seven days of competitive growth (Fig 8A). A similar phenotype, although not as
pronounced, was observed when the Newman wild-type and pepZ mutant were
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cocultured with shaking in peptide based media. The ratio of pepZ mutant to parent cells
recovered after 24 hours of growth was 1: 0.68, which steadily decreased to 1: 0.43 at day
5, and 1: 0.283 following seven days of growth (Fig. 8B). Competitive growth analysis of
the USA300 FPR wild-type and pepZ mutant strain inoculated together in 10% milk
media in 1:1 ratio resulted in a ratio of 1: 0.125 after 24 hours of static growth (Fig. 9A).
This was followed by a continual decline of viable pepZ mutant cells recovered over
seven days of competitive growth; resulting in a ratio of 1: 0.01 at day 7. Further
coculture analysis of the USA300 FPR strains performed in aerated milk media showed
an impaired phenotype for the pepZ mutant as well, in which the ratio of parent to mutant
cells was 1: 0.49 after 24 hours, 1: 0.17 at day 3, 1: 0.13 at day 4, and approximately 1:
0.01 days 5-7 (Fig. 9B).

Figure 8. Competitive Growth Analysis of a Newman pepZ mutant and Parent Strain in Peptide
Based Media. Newman wild-type and pepZ mutant strains were cocultured in 10% milk media at 37˚C (A)
static and (B) shaking. The competitive index was derived from daily viable cell counts relative to the
initial 1:1 inoculum. The standard deviation of 3 independent experiments is shown. Significant values (*)
were determined using a Student’s t test (p<0.05).
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Figure 9. Competitive Growth Analysis of a USA300 FPR pepZ mutant and Parental Strain in
Peptide Based Media. USA300 FPR wild-type and pepZ mutant strains were cocultured in 10% milk
media at 37˚C (A) static and (B) shaking. The competitive index was derived from daily viable cell counts
relative to the initial 1:1 inoculum. The standard deviation of 3 independent experiments is shown.
Significant values (*) were determined using a Student’s t test (p<0.05).

When grown statically in TSB, the Newman wild-type and pepZ mutant resulted in a
growth ratio of 1: 0.311 after 24 hours, and a final ratio of 1: 0.052 after seven days (Fig
10A). Newman wild-type and pepZ mutant strains grown in aerated TSB coculture
showed a decrease in viable pepZ mutant cells after 24 hours (ratio of 1: 0.516) followed
by six and seven day ratios of 1: 0.03 (Fig. 10B). In the USA300 FPR wild-type and pepZ
mutant static TSB cocultures, growth ratios of 1: 0.09 after 24 hours, and 1: 0.003 after
seven days of competitive growth, were identified (Fig. 11A). USA300 FPR wild-type
and pepZ mutant cocultures grown in aerated TSB yielded impaired mutant cell viability
after 24 hours, resulting in a growth ratio of 1: 0.405. Further loss of viability was
demonstrated in the pepZ mutant following seven days of competitive growth, declining
to a ratio of 1: 0.018 (Fig. 11B).
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Figure 10. Competitive Growth Analysis of a Newman pepZ mutant and Parent Strain in TSB.
Newman wild-type and pepZ mutant strains were cocultured in TSB at 37°C (A) static and (B) shaking.
The competitive index was derived from daily viable cell counts relative to the initial 1:1 inoculum. The
standard deviation of 3 independent experiments is shown. Significant values (*) were determined using a
Student’s t test (p<0.05).

Figure 11. Competitive Growth Analysis of a USA300 FPR pepZ mutant and Parent Strain in TSB.
USA300 FPR wild-type and pepZ mutant strains were cocultured in TSB at 37°C (A) static and (B) shaking.
The competitive index was derived from daily viable cell counts relative to the initial 1:1 inoculum. The
standard deviation of 3 independent experiments is shown. Significant values (*) were determined using a
Student’s t test (p<0.05).
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USA300 FPR wild-type and pepZ mutant cocultures exploring long-term competitive
growth under static growth conditions identified that maximum loss of viability in the
mutant occurs after one week in both TSB and peptide based media. When cultured in
TSB, USA300 FPR wild-type and pepZ mutant growth ratios of 1: 0.118 after one week,
1: 0.036 after three weeks of growth and 1: 0.129 after four weeks of static growth (Fig.
12A). Growth ratios observed of 1: 0.01 were determined after one week of growth for
the USA300 FPR cocultures in milk media, which continued through week four (Fig
12B). In the Newman wild-type and pepZ mutant cocultures, a growth ratio of 1: 0.025
was identified after one week of competitive growth in static peptide based media, with
an apparent recovery (CI=1: 0.161) after two weeks (Fig. 13A). This was followed by a
decline in pepZ mutant cells to a ratio of 1: 0.08 following competitive growth after three
weeks and, 1: 0.06 after four weeks. Competitive growth analysis of Newman wild-type
and pepZ mutant cocultures grown under static growth conditions in TSB resulted in an
average growth ratio of 1: 0.05 following one week of competitive growth, slightly
decreasing to growth ratios of 1: 0.04 weeks 2-4 (Fig. 13B).
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Figure 12. Competitive Growth Analysis of a USA300 FPR pepZ mutant and Parent Strain. USA300
FPR wild-type and pepZ mutant strains were cocultured together in (A) TSB and (B) 10% milk media at
37˚C static. The competitive index was derived from weekly viable cell counts relative to the initial 1:1
ratio inoculum. The standard deviation of 3 independent experiments is shown. Significant values (*) were
determined using a Student’s t test (p<0.05).

A

B

Figure 13. Competitive Growth Analysis of a Newman pepZ mutant and Parent Strain. Newman wildtype and pepZ mutant strains were cocultured together in (A) 10% milk media and (B) TSB while grown at
37˚C static. The competitive index was derived from weekly viable cell counts relative to the initial 1:1
ratio inoculum. The standard deviation of 3 independent experiments is shown. Significant values (*) were
determined using a Student’s t test (p<0.05).

Anaerobic Stress Profiling of PepZ using Chemically Defined Media. The role of
PepZ in response to anaerobic conditions was assessed using chemically defined media,
to identify changes in growth patterns when limited for both oxygen and a variety of
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nutrient sources. This was performed using amino acid limiting media, mannitol salt agar
(MSA), phosphate limiting media, and glucose limiting media. Agar plates for each of
these conditions were inoculated using three single Newman or USA300 FPR wild-type
or pepZ mutant colonies, and grown in parallel, aerobically and anaerobically, overnight
at 37°C. We identified that, in the absence of oxygen, the Newman and USA300 FPR
pepZ mutant strains fail to proliferate when limited for amino acids (Fig. 14). The
USA300 FPR pepZ mutant also showed impairment when grown under anaerobic
conditions limited for phosphate, when compared to the wild-type (Fig. 15). Furthermore,
the USA300 FPR pepZ mutant also failed to grow under anaerobic conditions when
grown on MSA, suggesting impaired mannitol utilization when grown in oxygen limited
conditions (Fig. 16).

WT

WT

pepZ

pepZ

Figure 14. Anaerobic Growth Analysis of pepZ mutants using Amino Acid Limited Media. Anaerobic
growth comparison on chemically defined media limited for amino acids demonstrated an impaired ability
in the mutant strains (A) USA300 FPR pepZ and (B) Newman pepZ to grow. WT refers to wild-type, and
the associated pepZ mutant is indicated as pepZ on the figure.
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WT

pepZ

Figure 15. Anaerobic Growth Analysis of a USA300 FPR pepZ mutant Limited for Phosphate.
Anaerobic growth comparison of USA300 FPR and its pepZ mutant on phosphate limiting media identified
an impaired ability in the mutant strain to grow. USA300 FPR wild-type is shown as WT and the associated
pepZ mutant is indicated as pepZ on the figure.

WT

pepZ

Figure 16. Anaerobic Growth Analysis of a USA300 FPR pepZ mutant on Mannitol Salt Agar.
Anaerobic growth comparison of USA300 FPR and its pepZ mutant on MSA demonstrates a decreased
ability in the mutant strain to utilize mannitol. USA300 FPR wild-type is shown as WT and the associated
pepZ mutant is indicated as pepZ on the figure.

Evaluating the Role of PepZ in S. aureus Carbon Utilization using Chemically
Defined Media. The proteolytic activity of aminopeptidases in part provides cellular
sources of energy and nutrition. This is often achieved through the catabolism of amino
acids, which result in metabolic by-products that converge as intermediates in central
metabolic pathways. We therefore explored the role of PepZ in carbon utilization using
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chemically defined liquid media, enriched with 100 µg ml-1 of galactose, ribose, lactose,
mannose, fructose, trehalose, raffinose, D-glucosamine or xylose. Exponentially growing
cells of USA300 FPR, SH1000 and Newman were assessed in parallel with their pepZ
mutants. In this experiment, identical carbon utilization profiles and patterns of growth
were identified across all strains (data not shown). These results suggest no direct role for
PepZ in the carbon based cellular energy status of S. aureus.

Characterization of the Role of PepZ in Membrane Integrity and Autolysis. The
intracellular processing of damaged proteins is vital to cell stability in all organisms
[Nandi et al., 2006]. As such, peptide turnover is often mediated through the proteolytic
activities of aminopeptidases, which may be crucial to cell wall degradation and
biosynthesis as a result of cell autolysis [Rawlings and Barrett, 2004]. We therefore
sought to characterize the role of PepZ in cell wall stability. This was examined using
penicillin-G and Triton X-100 to induce cell lysis in the parent strains USA300 FPR and
Newman, and their respective pepZ mutants. Penicillin-G induced cell lysis was assayed
using exponentially growing cells in TSB containing 0.4 ug ml-1 penicillin-G [Fujimoto
and Bayles, 1998]. Cell lysis, monitored in 30 minute intervals by turbidity change, did
not reveal any alterations in either background between the pepZ mutant and wild-type
strains (data not shown). Triton X-100 cell lysis experiments were carried out using
exponentially growing cells resuspended in 0.05M Tris-HCl (pH 7.6) containing 0.05%
Triton X-100. Cultures were incubated at 30°C shaking and measured for changes in
turbidity in 30 minute intervals [Mani et al., 1993; Shaw et al., 2005]. In this experiment
we identified an increase in parent strain viability when compared to the mutants (Fig.
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17). This phenotype was more prominent in Newman, in which mutant strain survival
decreased by approximately 2-fold at 60, 90 and 120 minutes. This was followed by a
3.86-fold final reduction of pepZ mutant cells when compared to the parent. As for the
USA300 FPR strains, a decrease in survival of 1.2-fold was identified at 30 minutes for
the mutant, followed by decreases of 1.4-fold at 60 minutes, 1.3-fold at 90 minutes, 1.2fold at 120 minutes and 1.4-fold at 150 minutes when compared to the parent strain after
exposure to cell lysis inducing conditions.

Figure 17. The Role of PepZ in Membrane Integrity and Autolysis. The effect of Triton X-100
mediated cell lysis on parent strains Newman (◆) and USA300 FPR (X), and their mutant derivatives
Newman pepZ (■) and USA300 FPR pepZ (●). Results are represented as percent survival measured as
OD600 at the specified time intervals from 3 independent experiments (+/- SD). Significant values (*) were
determined using a Student’s t test (p<0.05).

Evaluating the Role of PepZ in Cellular Survival Following Exposure to Elevated
Temperature. We next sought to investigate the role of PepZ in response to increased
temperatures, using heat shock and adaptation experiments, as proteolytic processing or
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turnover of misfolded proteins due to increased temperatures is a common function of
aminopeptidases. These experiments were performed at temperatures of 55°C using cells
resuspended in sterile TSB at an OD600 of 0.2. Heat shock was induced by placing
cultures in a 55°C water bath for 30 minutes and before returning them to standard
growth conditions at 37°C, with shaking. Cell viability was monitored in 30 minute
intervals by optical density readings at OD600 [Shaw et al., 2008]. We identified no
alteration in either background between the pepZ mutant and wild-type strain when
grown under these conditions (data not shown). A role for PepZ in heat adaptation was
assessed using exponentially growing cells in TSB, incubated at 55°C with shaking. Cell
death was monitored by viable cell counts performed in 20 minute intervals for two hours
from two independent experiments [Shaw et al., 2008]. What we identified was a
decreased capacity for survival in the Newman pepZ mutant strain compared to the wildtype (Fig. 18). Following 20 minutes of incubation at 55˚C, Newman pepZ mutant cells
decreased by 60-fold when compared to the parent, followed by undetectable levels of the
mutant at 40 minutes. The USA300 FPR wild-type and pepZ mutant strains lost viability
at equivalent rates, and were undetectable after 60 minutes of incubation at 55°C.
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Figure 18. The Role of PepZ in Response to Elevated Temperatures. Wild-type strains Newman (■)
and USA300 FPR (▲) with their mutant derivatives Newman pepZ (●) and USA300 FPR pepZ (◆) were
characterized for variations in adaptation to heat stress at 55°C. We identified a decreased capacity for
survival in the Newman pepZ mutant strain compared to the wild-type, whereas the USA300 FPR wildtype and pepZ mutant strains lost viability at equivalent rates. Data are represented as an average percent
survival from duplicate experiments. Significant values (*) were determined using a Student’s t test
(p<0.05).

Assessing the Role of PepZ in Response to Oxidative Stresses. Many stresses the
bacterial cell encounters can result in protein denaturing and damage; one such being
oxidative stress. We therefore sought to explore the potential role of PepZ in protein
stability and turnover in response to oxidative stress induced by hydrogen peroxide. This
was explored in the wild-type strains Newman and USA300 FPR, and their mutant
derivatives. We performed this assay using PBS washed cells resuspended in sterile PBS
containing 7.5mM H2O2. Cultures were incubated with shaking at 37°C, and monitored at
20 minute intervals by viable cell counts, performed in PBS containing 10 mg ml -1
catalase for H2O2 inactivation [Watson et al., 1998]. We identified decreased cell
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viability for all strains, with no variation between the wild-types and mutants (data not
shown). These results suggest no role for PepZ in the cellular response to oxidative stress,
at least under the conditions tested.

General Stress Profiling of pepZ mutant Strains using a Modified Kirby-Bauer
Assay. We examined the role of PepZ in cellular survival using a variety of chemical
stressors. This was explored using disk diffusion assays to identify changes in
susceptibility of pepZ mutants and their parent strains. Disk diffusion assays were
performed in triplicate as described above, without the addition of X-Gal [Peng et al.,
1988]. Zones of inhibition were measured in mm to identify changes in susceptibility to
the various chemical compounds (Table 3). In doing so we identified increased
menadione resistance in the USA300 FPR pepZ mutant (15.6 mm) when compared to the
parent (36 mm), resulting in a 2.3-fold change. Further analysis revealed the average
minimum inhibitory concentration of menadione in the USA300 FPR strain was 1.46 µg
ml-1, whilst the mutant was 5.1 µg ml-1. In the Newman strain, a limited increase in
susceptibility to hydrogen peroxide was identified in the Newman pepZ mutant (51 mm)
when compared to the parent (46.3 mm). Additionally, limited increased menadione
susceptibility in the Newman pepZ mutant (17 mm) was identified when compared to the
parent (21 mm).

Characterization of the Subcellular Localization of PepZ. Subsequent to the
nutritional analysis of PepZ in S. aureus, we sought to explore a role for PepZ in protein
stability using proteomic analysis. The analysis of preliminary mass spectrometry data
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obtained in our laboratory had previously identified PepZ in secreted protein fractions
from 15 hour cultures harvested from the SH1000 wild-type. This identified extracellular
localization of PepZ may be the result of stationary phase cell lysis, or legitimate
secretion. Therefore we sought to investigate further the subcellular localization of this
aminopeptidase, as it is predicted to be an intracellular protein. To examine this, we
constructed wild-type strains of S. aureus USA300 FPR and Newman containing a pepZ
gene bearing a 6-His tag, using the shuttle vector pMK4. We then purified both
intracellular and secreted proteomes from these strains at hours 5 and 15, to monitor the
levels of PepZ both inside and outside of the cell. Extracting proteomes at these time
points corresponds to post exponential and stationary phase growth, respectively,
allowing us to clarify the potential for PepZ secretion during earlier growth stages that
would not be associated with cell lysis. We used Western blot detection methods,
targeting the 6-His tag, to identify levels of PepZ expression using a SuperSignal West
HisProbe Kit. Using this method, we identified PepZ in intracellular and secreted protein
fractions extracted from USA300 FPR and Newman cultures at hours 5 and 15. Protein
fractions collected from the Newman background at hours 5 (Fig.19A) and 15 (Fig. 19B)
identified a 55 kDa band corresponding to the expected size of PepZ at both of the time
points in the cytoplasmic and secreted fractions.
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Figure 19. Western Blot Detection of PepZ in Strain Newman. Western blot analysis of Newman
pMK4::pepZ 6-His and empty vector controls detected a 55 kDa protein band in both intracellular (I/C) and
secreted (E/C) protein samples collected at (A) 5 and (B) 15 hours. Empty vector controls are labeled as
control. Protein samples were standardized to 1 µg of total protein per lane.

Further, a pMK4 empty vector was run concurrently as a negative control from
intracellular and secreted protein samples collected from 5 and 15 hour cultures, which
did not detect protein bands at 55 kDa. Similarly, a 55 kDa band was identified in the
USA300 FPR background at hours 5 (Fig. 20A) and 15 (Fig. 20B) from both intracellular
and secreted protein fractions. Again, a pMK4 empty vector was run concurrently as a
negative control from intracellular and secreted protein samples collected from 5 and 15
hour cultures, which did not detect protein bands at 55 kDa. Including the pMK4 negative
control ensured the produced 55 kDa band was not a false positive produced from protein
samples collected from the pMK4 vector, which was used to construct the 6-His strains.

Figure 20. Western Blot Detection of PepZ in Strain USA300 FPR. Western blot analysis of USA300
FPR pMK4::pepZ 6-His and empty vector control detected a 55 kDa protein band in both intracellular (I/C)
and secreted (E/C) protein samples collected at (A) 5 and (B) 15 hours. Empty vector controls are labeled
as control. Protein samples were standardized to 1 µg of total protein per lane.
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Proteomes were further explored for cellular localization patterns of PepZ from
intracellular and secreted protein samples collected hourly for eight hours from
synchronized cultures in the Newman background. Protein samples demonstrated an
increased abundance of PepZ in cytoplasmic fractions at hours two through four, which
decreased at later time points (Fig. 21A). In comparison, PepZ detection in the secretome
remained relatively consistent through the eight hour period, with a 55 kDa band detected
at similar levels of protein abundance at hours three through eight (Fig. 21B). From these
experiments, we have identified the potential for PepZ secretion in S. aureus, suggesting
a possible extracellular role for this aminopeptidase.

Figure 21. Detection of PepZ during Continuous Growth of Strain Newman. Western blot analysis of
Newman bearing a pepZ::6-His identified changes in PepZ (55 kDa) abundance over an eight hour period
from intracellular (A) and extracellular samples (B). Samples collected at hour 1 failed to identify any
detectable protein, and are not shown. Protein samples were standardized to 1 µg of total protein per lane.

Exploring Potential Substrates for the PepZ Enzyme using 2D Difference Gel
Electrophoresis (DIGE) and Tandem Mass Spectrometry. Experimental data
collected thus far demonstrates an important role for PepZ in S. aureus virulence.
Additionally, we have shown that PepZ is capable of being externalized during the
growth of S. aureus strains. We therefore sought to clarify how PepZ fulfills its
enzymatic role at the level of protein stability. Accordingly, we probed the proteomes of
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pepZ mutant and parental strains to identify alterations in the stability of proteins both
within, and outside, the cell. Proteome profiling of secreted and intracellular proteomes
from USA300 FPR wild-type and pepZ mutant strains using 2D-DIGE coupled with mass
spectrometry was performed in collaboration with the ICBR facility at the University of
Florida. 2D-DIGE analysis provides the ability to quantify sample specific changes in
protein abundance using a single gel and fluorescent labeling. Protein samples are mixed
and run together with an internal standard, allowing protein samples to be resolved to the
same intensity and measured relative to the internal reference. Gels can then them be
visualized for changes in color, indicating altered protein abundance levels or changes in
proteolytic processing. As such, this method of analysis was selected to identify the effect
of PepZ on changes in the protein profile of S. aureus. Briefly, intracellular and secreted
proteomes were collected in triplicate from USA300 FPR wild-type and pepZ mutant
strains from three hour cultures, corresponding to peak expression of pepZ. Protein
fractions were then purified and transferred to the ICBR facility at the University of
Florida. Protein spots determined with increased or decreased protein levels of 1.2-fold or
more were then extracted and analyzed for identification using mass spectrometry and
MASCOT software.

Differential analysis of intracellular fractions identified eleven protein spots that
demonstrated fold changes ranging from -7 to 1.74 in at least six of nine 2-D protein map
images (p<0.05) between the wild-type and mutant strains (Fig. 22). From the eleven
spots identified from in gel analysis, mass spectrometry identified 30 total proteins with
two unique peptides and a 95% protein identification probability as determined by protein
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Prophet using Scaffold software, in which multiple proteins were identified for each spot
(Table 5). Additionally, protein spots 1425, 1780, 1806, 1818, 1831, 2046 and 2139
identified variations in protein molecular weight, which may be due to altered protein
cleavage in the absence of PepZ (Table 6). These proteins include: autolysin, alphahemolysin, N-acetylmuramoyl-L-alanine amidase domain protein, 50s ribosomal
proteins, 30s ribosomal proteins, elastin binding proteins, staphopain A, foldase, Alkaline
shock protein, putative lipoprotein and ATP-dependent Clp protease.

Figure 22. Intracellular Proteome Analysis of S. aureus USA300 FPR and its pepZ mutant using 2DDIGE. (A) Differential analysis of intracellular proteins from the USA300 FPR wild-type and pepZ mutant
strains following isoelectric focusing using a 24 cm pH 3 to 10 non linear IPG strip at 10 k volts. USA300
FPR wild-type proteins are indicated by the green fluorescent color and pepZ mutant proteins are shown in
red. (B) In gel analysis identified 11 proteins with varied levels of abundance by at least 1.5 fold (p<0.05),
which were further characterized using mass spectrometry analysis.
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Table 5. Intracellular Proteome Analysis of S. aureus USA300 FPR and its pepZ mutant using Mass Spectrometry
Spot

Protein [A]

1831

50S
ribosomal
protein L4
RplD
(USA300)

2139

50S
ribosomal
protein L6
RplF
(USA300)
5'nucleotidas
e,
lipoprotein
e(P4)
family
SAUSA300
_0307
Nacetylmura
moyl-Lalanine
amidase
Sle1(USA3
00)
50S
ribosomal
protein L19
RplS
(USA300)
Alkaline
shock
protein 23
Asp23
(USA300)

1818

ATP
synthase
subunit
delta AtpH
(USA300)

1806

1520

1425

2046

Peptides
[A]

4

Protein [B]
Uncharacteri
zed
leukocidinlike protein 2
SAUSA300_
1975

4

50S
ribosomal
protein L4
RplD
(USA300)

6

ABC
transporter,
substratebinding
protein
SAUSA300_
0618

3

5

Foldase
protein PrsA
(USA300)
50S
ribosomal
protein L14
RplN
(USA300)

Peptides
[B]

3

3

3

2

4

Protein [C]
50S
ribosomal
protein L6
RplF
(USA300)

Staphopain
A
SAUSA300_
1890

Secretory
antigen SsaA
(USA300)]

50S
ribosomal
protein L25
PlY
(USA300)
50S
ribosomal
protein L21
RplU
(USA300)

Peptides
[C]

Peptides
[D]

Protein [E]

3

ATPdependent
Clp protease
proteolytic
subunit
(USA300)

2

Uncharacteri
zed
leukocidinlike protein 2
SAUSA300_
1975

2

Uncharacteri
zed
leukocidinlike protein 2
SAUSA300_
1975

2

5.01

2

3.68

Protein [D]

2

2

4

Protein [F]

Peptides
[F]

Fold
∆

-7

30S
ribosomal
protein S2
RpsB
(USA300)
Putative
uncharacteri
zed protein
SAUSA300_
0602

3

30S
ribosomal
protein S11
RpsK
(USA300)

2

3

5.37

3.22

2.34

3

3

Peptides
[E]

Elastinbinding
protein EbpS
(USA300)

1.54

2
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1685

50S
ribosomal
protein L1
RplA
(USA300)

1780

50S
ribosomal
protein L6
RplF
(USA300)

1026

Enolase
Eno
(USA300)

1048

Protein
RecA
(USA300)

4

7

3

9

Uridylate
kinase PyrH
(USA300)

Putative
lipoprotein
SAUSA300_
0372

Autolysin
Atl
(USA300)
3-oxoacyl[acyl-carrierprotein]
synthase 2
FabF
(USA300)

1.54

2

4

3

7

50S
ribosomal
protein L4
rplD
(USA300)
NADspecific
glutamate
dehydrogena
se GudB
(USA300)

Enolase Eno
(USA300)

3

Uncharacteri
zed
leukocidinlike protein 2
SAUSA300_
1975

2

ATPdependent
Clp protease
proteolytic
subunit
(USA300)

1.49

2

2

4

1.51

Autolysin
Atl
(USA300)

3

Immunoglob
ulin-binding
protein Sbi
(USA300)

3

Adenylosuc
cinate lyase
PurB
(USA300)

2

1.74

*Mass spectrometric analysis identified 30 proteins from the 11 protein spots having fold changes of 1.5 fold or greater (p<0.05) between the USA300
FPR and pepZ mutant intracellular proteomes. Proteins were identified by unique peptide values of two or more and a 95% protein identification
probability as determined by protein Prophet for each spot using Scaffold software.
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Table 6. Intracellular Protein Spots Identified by 2D-DIGE and Mass Spectrometry
Analysis to Have Altered Protein Stability
2D
Spot MW

Protein Expected
Expected
Expected
Expected
[A]
MW [A] Protein [B] MW [B] Protein [C] MW [C] Protein [D] MW [D]
NFoldase
acetylmuram
protein
oyl-L-alanine
PrsA
amidase Sle1
1425 33 kDa (USA300) 36 kDa (USA300)
ATPUncharacteri
dependent
zed
50S
Clp protease
leukocidinribosomal
Putative
proteolytic
like protein
protein L6
lipoprotein
subunit
2
RplF
SAUSA300_
ClpP
SAUSA300
1780 18 kDa (USA300) 20 kDa 0372
21 kDa (USA300)
22 kDa _1975
40 kDa
Uncharacteri
ATPzed
50S
dependent
leukocidinribosomal
Clp protease
like protein
Staphopain
protein L6
proteolytic
2
A
RplF
subunit ClpP
SAUSA300
SAUSA300
1806 17 kDa (USA300) 20 kDa (USA300)
22 kDa _1975
40 kDa _1890
44 kDa
ATP
synthase
subunit
Elastindelta
binding
AtpH
protein EbpS
1818 18 kDa (USA300) 20 kDa (USA300)
53 kDa
Uncharacteri
zed
50S
50S
leukocidinribosomal
ribosomal
like protein
protein L6
protein L4
2
181 RplF
RplD
SAUSA300
1831 kDa (USA300) 20 kDa (USA300)
22 kDa _1975
40 kDa
50S
50S
30S
Putative
ribosomal
ribosomal
ribosomal
uncharacteri
protein
protein L14
protein S11
zed protein
L21 RplU
RplN
RpsK
SAUSA300
2046 10 kDa (USA300) 11 kDa (USA300)
13 kDa (USA300)
14 kDa _0602
19 kDa
Alkaline
shock
protein 23
Asp23
2139 9 kDa (USA300) 19 kDa
*In the absence of PepZ, protein spots 1425, 1780, 1806, 1818, 1831, 2046 and 2139 were identified to
have variations in 2D-DIGE predicted molecular weight values compared to mass spectrometry predicted
protein molecular weight values. These results indicate potential changes in intracellular protein
processing events in the absence of PepZ. Protein cleavage was determined by +/- 2 kDa in protein
molecular weight changes, determined between the two analyses.
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2D-DIGE performed on the secreted protein fractions produced 83 protein spots that
demonstrated fold changes ranging from -1.33 to 15.05 (p<0.05) between the USA300
FPR wild-type and pepZ mutant strains (Fig. 23). Mass spectrometry and Scaffold
software analysis identified 43 proteins from the 83 spots shown to vary in protein
intensity and abundance between the pepZ mutant and wild-type secretomes (Table 7).

Figure 23. Secretome Analysis of S. aureus USA300 FPR and its pepZ mutant using 2D-DIGE. (A)
Differential analysis of secreted proteins from the USA300 FPR wild-type and pepZ mutant strains
following isoelectric focusing using a 24 cm pH 3 to 10 non linear IPG strip at 10 k volts. USA300 FPR
wild-type proteins are indicated by the green fluorescent color and pepZ mutant proteins are shown in red.
(B) In gel analysis identified 83 proteins with varied levels of abundance by at least 1.5 fold (p<0.05),
which were further characterized using mass spectrometry analysis. Mass spectrometry analysis failed to
identify proteins for 28 of the 83 spots, which are listed in appendix 1.

Scaffold software analysis identified the proteins according to unique peptide sequences,
in which to two unique peptides and a 95% protein identification probability as
determined by protein Prophet was used for protein identification. Based on these
parameters, proteomic analysis failed to identify proteins in 28 of the 83 protein spots.
Additionally, protein spots 3074, 591, 535, 630, 586, 2351, 579, 575, 736, 819, 619,
1788, 791, 1337, 1282, 1405, 1271, 2639, 2095, 2083, 1675, 2159, 2831, 3347, 2617,
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Table 7. Secretome Analysis of S. aureus USA300 FPR and its pepZ mutant using Mass Spectrometry
Spot

Peptides
[A]

591

Protein [A]
Triacylglycerol lipase
SAUSA300_0320
Triacylglycerol lipase
SAUSA300_0320
Thermonuclease Nuc (USA300)
Triacylglycerol lipase
SAUSA300_0320
Triacylglycerol lipase
SAUSA300_0320

535

Autolysin Atl (USA300)

22

630

Autolysin Atl (USA300)
Triacylglycerol lipase
SAUSA300_0320
Triacylglycerol lipase
SAUSA300_0320
Uncharacterized leukocidin-like
protein 1 SAUSA300_1974
Serine-aspartate repeatcontaining protein E SdrE
(USA300)
Uncharacterized leukocidin-like
protein 1 SAUSA300_1974

581
577
3074
546

586
211
1736

280
2351

Protein [D]

Peptides
[D]

Fold
∆

-2.38
-2.15

8

-2.12

15

13

-2

10

-1.94

7

Autolysin Atl (USA300)
Triacylglycerol lipase
SAUSA300_0320
Triacylglycerol lipase
SAUSA300_0320

4

-1.9

11

Autolysin Atl (USA300)

3

-1.88

2

-1.88

7

-1.83

5

-1.83

4

603

Triacylglycerol lipase
SAUSA300_0320

9

575

Autolysin Atl (USA300)

13

619

Peptides
[C]

7
5

7

819

Protein [C]

-2.41

Autolysin Atl (USA300)

Triacylglycerol lipase
SAUSA300_0320
N-acetylmuramoyl-L-alanine
amidase domain protein
SAUSA300_2579
Triacylglycerol lipase
SAUSA300_0320

Peptides
[B]

2

579

736

Protein [B]

17

-1.74
Triacylglycerol lipase
SAUSA300_0320
N-acetylmuramoyl-L-alanine
amidase domain protein
SAUSA300_2579
Triacylglycerol lipase
SAUSA300_0320
N-acetylmuramoyl-L-alanine
amidase domain protein
SAUSA300_2579

3

Elongation factor G
(USA300)

2

5

-1.72

7

4

-1.66
Dihydrolipoamide
acetyltransferase
SAUSA300_0995

3

4
10

-1.73

-1.65

-1.64
Triacylglycerol lipase
SAUSA300_0320

10
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Autolysin Atl (USA300)

5

-1.62

1788

Uncharacterized leukocidin-like
protein 1 SAUSA300_1974

8

605

Triacylglycerol lipase
SAUSA300_0320

6

791
433

1337
1170

1282
1405
1293
1294
1424
232
1271
2639
2095
2083
1675
2159
2831
3347
2617

Triacylglycerol lipase
SAUSA300_0320
Triacylglycerol lipase
SAUSA300_0320

Autolysin Atl (USA300)
Dihydrolipoyl dehydrogenase
IpdA (USA300)
Putative cell wall surface anchor
family protein SAUSA300_2436
Putative cell wall surface anchor
family protein SAUSA300_2436
Putative cell wall surface anchor
family protein SAUSA300_2436
Putative cell wall surface anchor
family protein SAUSA300_2436
Putative cell wall surface anchor
family protein SAUSA300_2436
Clumping factor A ClfA
(USA300)
Putative cell wall surface anchor
family protein SAUSA300_2436
Serine protease SplE (USA300)
Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
Triacylglycerol lipase
SAUSA300_0320
Alpha-hemolysin
SAUSA300_1058
Staphopain A SAUSA300_1890
Alpha-hemolysin
SAUSA300_1058
Serine protease SplE (USA300)

15

N-acetylmuramoyl-L-alanine
amidase domain protein
SAUSA300_2579
N-acetylmuramoyl-L-alanine
amidase domain protein
SAUSA300_2579
Dihydrolipoamide
acetyltransferase
SAUSA300_0995

2

-1.61

6

-1.59

6

N-acetylmuramoyl-L-alanine
amidase domain protein
SAUSA300_2579

8

Glycerol phosphate
lipoteichoic acid synthase
ItaS (USA300)

2

-1.58

3

16

-1.58
Putative cell wall surface anchor
family protein SAUSA300_2436

8

4

Triacylglycerol lipase
SAUSA300_0320

3

-1.57
-1.57

13

Glycerol phosphate lipoteichoic
acid synthase ItaS strain
USA300)

3

10

Autolysin Atl (USA300)

3

-1.56
Enolase Eno (USA300)

2

-1.55

17

-1.55

12

-1.53

10
9
7
6
14

Autolysin Atl (USA300)
Clumping factor B ClfB
(USA300)

5

-1.51

7

-1.51

Autolysin Atl (USA300)
Serine protease SplF (USA300)
N-acetylmuramoyl-L-alanine
amidase Sle1 (USA300)

6
3

-1.5
1.46

3

5
8

2

1.49
1.51

Immunoglobulin-binding protein
Sbi (USA300)

3

2
8
20
2

Panton-Valentine leukocidin,
LukS-PV (USA300)

1.52
1.54
1.55

Panton-Valentine leukocidin,
LukS-PV (USA300)
Serine protease SplF (USA300)

2
3
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1.56
1.57

2098

Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058

2150

Alpha-hemolysin
SAUSA300_1058

2198
2094

2092
2882

Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
Staphopain A SAUSA300_1890

2147

Alpha-hemolysin
SAUSA300_1058

2162

2152
2131
2177
2144
2093

2086

2220

2261

Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
Alpha-hemolysin
SAUSA300_1058
1-phosphatidylinositol
phosphodiesterase Plc
(USA300)
Alpha-hemolysin
SAUSA300_1058

14
13
8

8

13

Panton-Valentine leukocidin,
LukS-PV (USA300)
N-acetylmuramoyl-L-alanine
amidase Sle1 (USA300)
Panton-Valentine leukocidin,
LukS-PV (USA300)
1-phosphatidylinositol
phosphodiesterase Plc
(USA300)
1-phosphatidylinositol
phosphodiesterase Plc
(USA300)

9

1-phosphatidylinositol
phosphodiesterase Plc
(USA300)

4

4
3

12

2

2

1.63
1.64
1.65

1-phosphatidylinositol
phosphodiesterase Plc
(USA300)
Panton-Valentine leukocidin,
LukS-PV (USA300)

2

3

1.7
Uncharacterized leukocidinlike protein 1
SAUSA300_1974

6

1.75
1.77

Panton-Valentine leukocidin,
LukS-PV (USA300)

3

1.82
1.82

6

1.82
1-phosphatidylinositol
phosphodiesterase Plc
(USA300)

2

7

5

1.59

1.61

16

7

1.57

6

6
20

2

1.58
N-acetylmuramoyl-L-alanine
amidase Sle1 (USA300)

18
2

10

Leukotoxin LukE
(USA300)

1.93

2.74
1-phosphatidylinositol
phosphodiesterase Plc
(USA300)

3

15.05

* Mass spectrometric analysis identified 43 proteins from the 83 protein spots having fold changes of 1.5 fold or greater (p<0.05) in the USA300 FPR and pepZ
mutant secretomes. Proteins were identified by unique peptide values of two or more and a 95% protein identification probability as determined by protein
Prophet for each spot using Scaffold software.
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2198, 2094, 2098, 2150, 2162, 2092, 2882, 2147, 2152, 2131, 2177, 2144, 2093, 2086,
2220 and 2261 identified variations in protein molecular weight size due to potential
altered protein stability in the absence of PepZ (Table 8). These proteins include:
autolysin, alpha-hemolysin, N-acetylmuramoyl-L-alanine amidase domain protein,
glycerol phosphate lipoteichoic acid synthase, serine proteases SplE and SplF,
immunoglobulin-binding
phosphodiesterase,

protein,

thermonuclease,

staphopain
uncharacterized

A,

1-phosphatidylinositol

leukocidin-like

protein

1,

triacylglycerol lipase and Panton-Valentine leukocidin, LukS-PV.

Table 8. Secreted Protein Spots Identified by 2D-DIGE and Mass Spectrometry
Analysis to Have Altered Protein Stability
Spot

2D
MW

535

86
kDa

575

85
kDa

579

84
kDa

586

86
kDa

591

84
kDa

619

82
kDa

630

77
kDa

736

68
kDa

791

65
kDa

Protein
[A]
Autolysin
Atl
(USA300)
Autolysin
Atl
(USA300)
Autolysin
Atl
(USA300)
Autolysin
Atl
(USA300)
Autolysin
Atl
(USA300)
Autolysin
Atl
(USA300)
Autolysin
Atl
(USA300)
Triacylgly
cerol
lipase
SAUSA3
00_0320
Nacetylmur
amoyl-Lalanine
amidase
domain
protein
SAUSA3
00_2579

Expected
MW [A]

Protein
[B]

Expected
MW [B]

Triacylgly
cerol
lipase
SAUSA3
00_0320

76 kDa

137 kDa

137 kDa

137 kDa

137 kDa

137 kDa

137 kDa

137 kDa

76 kDa

69 kDa
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Protein
[C]

Expected
MW [C]

Protein
[D]

Expected
MW [D]

819

64
kDa

1271

52
kDa

1282

52
kDa

1337

52
kDa

1405

51
kDa

1675

41
kDa

1788

41
kDa

2083

33
kDa

2086

32
kDa

2092

33
kDa

2093

33
kDa

2094

33
kDa

Nacetylmur
amoyl-Lalanine
amidase
domain
protein
SAUSA3
00_2579
Autolysin
Atl
(USA300)
Glycerol
phosphate
lipoteicho
ic acid
synthase
ItaS
(USA300)
Glycerol
phosphate
lipoteicho
ic acid
synthase
ItaS
(USA300)
Autolysin
Atl
(USA300)
Immunogl
obulinbinding
protein
Sbi
(USA300)
Nacetylmur
amoyl-Lalanine
amidase
domain
protein
SAUSA3
00_2579
Alphahemolysin
SAUSA3
00_1058

Alphahemolysin
SAUSA3
00_1058
Alphahemolysin
SAUSA3
00_1058
Alphahemolysin
SAUSA3
00_1058
Alphahemolysin
SAUSA3
00_1058

69 kDa

137 kDa

74 kDa

74 kDa

Triacylgly
cerol
lipase
SAUSA3
00_0320

76 kDa

Triacylgly
cerol
lipase
SAUSA3
00_0320

76 kDa

1phosphati
dylinosito
l
phosphodi
esterase
Plc
(USA300)

37 kDa

137 kDa

50 kDa

69 kDa

36 kDa

36 kDa

36 kDa

36 kDa

36 kDa

76

Autolysin
Atl
(USA300)

137 kDa

2095

32
kDa

2098

32
kDa

2131

29
kDa

2144

29
kDa

2147

2150

35 kDa

Alphahemolysin
SAUSA3
00_1058

29
kDa

Alphahemolysin
SAUSA3
00_1058

36 kDa,

2159

29
kDa

29
kDa

29
kDa

Alphahemolysin
SAUSA3
00_1058
PantonValentine
leukocidin
, LukSPV
(USA300)

36 kDa

Autolysin
Atl
(USA300)

137 kDa

Uncharact
erized
leukocidin
-like
protein 1
SAUSA3
00_1974

39 kDa

36 kDa

36 kDa

PantonValentine
leukocidin
, LukSPV
(USA300)
Alphahemolysin
SAUSA3
00_1058

36 kDa

36 kDa

29
kDa

29
kDa

2177

35 kDa

Alphahemolysin
SAUSA3
00_1058

Alphahemolysin
SAUSA3
00_1058

2152

2162

PantonValentine
leukocidin
, LukSPV
(USA300)
PantonValentine
leukocidin
, LukSPV
(USA300)
Alphahemolysin
SAUSA3
00_1058
Alphahemolysin
SAUSA3
00_1058

1phosphati
dylinosito
l
phosphodi
esterase
Plc
(USA300)
1phosphati
dylinosito
l
phosphodi
esterase
Plc
(USA300)

37 kDa

37 kDa

Alphahemolysin
SAUSA3
00_1058

36 kDa

36 kDa

1phosphati
dylinosito
l
phosphodi
esterase
Plc
(USA300)

37 kDa

35 kDa

Alphahemolysin
SAUSA3
00_1058

36 kDa

35 kDa

36 kDa
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2198

28
kDa

2220

28
kDa

2261

28
kDa

2351

29
kDa

2617

23
kDa

2639

22
kDa

2831

18
kDa

2882

17
kDa

3347

33
kDa

3074

12
kDa

PantonValentine
leukocidin
, LukSPV
(USA300)
1phosphati
dylinosito
l
phosphodi
esterase
Plc
(USA300)

Autolysin
Atl
(USA300)
Uncharact
erized
leukocidin
-like
protein 1
SAUSA3
00_1974
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* In the absence of PepZ, the listed proteins were identified to have variations in 2D-DIGE predicted
molecular weight values compared to mass spectrometry predicted protein molecular weight values. These
results indicate potential changes in secreted protein cleavage, maturation and or activation events in the
absence of PepZ. Protein cleavage was determined by +/- 2 kDa protein molecular weight change
determined between the two analyses.
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Exploring the Role of PepZ in the Formation of Biofilms. Biofilms are sessile
microbial aggregates assembled in an adhesive structural matrix composed of
polysaccharides, DNA and proteins [Lawrence et al., 1991]. The switch of infectious
states from adhesion to invasion has been suggested to be primarily driven by the
interplay of proteases, and cell adhesion and colonization factors [McGavin et al., 1997].
Indeed, a number of recent studies [Boles and Horswill, 2008; Beenken et al., 2003; and
Tsang et al., 2008] have identified the modification of protein profiles via proteases
during the detachment stages of S. aureus biofilm formation. As such, we decided to
explore the role of PepZ on the formation of a biofilm. This experiment was performed in
triplicate in the wild-type strains, Newman and USA300 FPR, and their associated pepZ
mutants. The S. aureus strain RN6390 was used as a negative control in the biofilm
assays. From this experiment, we identified a minor defect in the ability the USA300 FPR
pepZ mutant to form a biofilm, where the average absorbance readings from eluted
crystal violet at 595 nm for the wild-type was determined to be 0.94 and 0.81 for the
pepZ mutant, which was measured using a BioTek Synergy2 96-well plate reader (Fig.
24). These results overall suggest a limited role for PepZ in the formation of a biofilm
under the conditions tested.
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Figure 24. The Role of PepZ in the Formation of an S. aureus Biofilm. Biofilm formation assays
performed in triplicate detected a slight reduction in the biofilms formed by the USA300 FPR pepZ mutant
strain when compared to the USA300 FPR parent strain. Biofilm formation was determined by crystal
violet absorbance readings at 595 nm using a 96-well BioTek Synergy-2 plate reader, identified to be 0.94
for the wild-type and 0.81 for the pepZ mutant. RN6390 was used as a negative control, with an average
biofilm absorbance reading of 0.088.

Analysis of the Importance of PepZ during Interaction with Components of the
Human Immune System. Evasion of host immune factors is vital to the survival and
persistence of pathogens within the host. Thus, experiments exploring the role of PepZ in
response to interactions with the human immune system were performed in collaboration
with Dr. Jan Potempa from the Jagiellonian University, Krakow, Poland. A human model
of macrophage survival and clearance was performed with the Newman wild-type and its
pepZ mutant strain in two independent experiments. Cell viability was monitored by
quantitative plating at hours 0, 2, 24, 48, 72 and 96 post-inoculum, yielding reduced
levels of survival in the Newman pepZ mutant strain. Viable counts identified a 15-fold
decrease in survival at 2 hours for the pepZ mutant when compared to the wild-type (Fig.
25). This was followed by further declines in mutant survival of 240-fold at 24 hours and
129-fold at 48 hours. These results suggest PepZ is important for host immune system
interaction, and evasion.
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Figure 25. Characterization of the Role of PepZ in Human Immune System Interactions. Human
models of macrophage survival and clearance was performed in strains Newman (X) and Newman pepZ (+).
The pepZ mutant showed a consistent impairment in viability while interacting with components of the
human immune system. Data is represented as CFU/well measured at the indicated time intervals from 2
independent experiments.

Further Characterization of the Role of PepZ in S. aureus Virulence using a Murine
Model of Wound Formation. We sought to corroborate our findings of alterations in
systemic virulence of pepZ mutant strains by investigating the role of this enzyme in
localized infections, using a murine model of abscess formation. Ten hairless, SKH-1
immunocompetent mice were inoculated subcutaneously in the right flank with 1 x 108
CFU of either the USA300 FPR wild-type or pepZ mutant. Infections were monitored for
seven days and any abscesses formed were harvested following animal euthanasia [Bunce
et al., 1992; Chan and Foster, 1998]. The bacterial load per abscess was determined by
recovery from abscess homogenates, and yielded 8.10 x 107 CFU per abscess for the
wild-type, or 85% of the original inoculum (Fig. 26). In contrast, 35% of the pepZ mutant
inoculum was recovered, or 3.51 x 107 CFU per abscess. This resulted in a 2.3-fold
reduction in bacterial load of the USA300 FPR pepZ mutant, which was found to be
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statistically significant (p<0.03). This further suggests that PepZ is required for full
virulence of S. aureus, and is not confined to a single strain or lineage.

Figure 26. PepZ is Required for Full Virulence of CA-MRSA Strains in a Murine Model of Wound
Formation. The USA300 FPR wild-type and pepZ mutant were used to subcutaneously inoculate 10 mice
8
each with a bacterial load of 1 x 10 . A 2.3-fold (p<0.03) bacterial load reduction of the USA300 FPR pepZ
mutant was identified Results are represented as CFU/abscess. The average CFU/abscess is indicated by a
bold marker for both wild-type and mutant.

Evaluating the Role of pepZ in CA-MRSA Sepsis using a Mouse Model. We next set
out to characterize the role of PepZ in S. aureus virulence using a CA-MRSA model of
murine sepsis. Ten CD-1 immunocompetent mice were inoculated via tail vein injection
with 100 µl of 1.00 x 108 CFU ml-1 USA300 FPR wild-type or pepZ mutant cells.
Strikingly, all mice inoculated with the USA300 FPR wild-type strain died within 24
hours following injection. In comparison, two of the ten mice injected with the USA300
FPR pepZ mutant strain died two days post inoculation, with the remaining eight
surviving the seven day experimental period (Fig. 27). These results are in accordance
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with all former virulence assays performed; further substantiating that PepZ is required
for full virulence of S. aureus.

Figure 27. The Role of pepZ in CA-MRSA Sepsis. Ten mice each were tail vein inoculated with either
the USA300 FPR (◆) wild-type or USA300 FPR pepZ (■) mutant. All mice inoculated with the USA300
FPR wild-type strain died within 24 hours following injection, compared to only two deaths for mice
injected with pepZ mutant cells. Data is represented as percent survival over time.
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Discussion

During a previous screen in our laboratory focused on the role of proteases in S. aureus
virulence, we identified a mutant in aminopeptidase Z as being attenuated in disease
causation. This phenotype, as determined using a murine model of septic arthritis, led us
to begin the initial characterization of PepZ to determine the role(s) it fulfills in S. aureus
physiology, nutrition and pathogenesis. BLAST analysis of the PepZ protein sequence
PepZ revealed homology to the cytoplasmic aminopeptidase M17 family of
exopeptidases (Fig. 28). Aminopeptidases serve an array of functions in the microbial cell
ranging from the degradation of damaged proteins, to providing sources of energy and
nutrition [Taylor, 1993, Chandu and Nandi, 2003; Patil et al., 2007; Miller, 1978]. It has
been speculated that the primary role of externalized aminopeptidases is to liberate free
amino acids from exogenous peptides, which are required for nutritional purposes and
continual cell growth [Maeda et al., 1996]. In addition to roles in nutrition,
aminopeptidase activity may be important in proteolytic cleavage events in a variety of
organisms [Gonzales and Robert-Baudouy, 1996]. Proteomic analysis using CA-MRSA
strains identified aminopeptidase PepV in early exponential and stationary phase
secretomes, as well as aminopeptidases PepS, PepP and PepT2 in stationary phase
secretomes [Burlak et al., 2007], suggesting a role for aminopeptidases beyond the
confines of the cell membrane. Thus, the basis of this study is driven by two
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hypothesized roles for PepZ in S. aureus; the first being in the processing of exogenous
oligopeptides for nutrition, and the second in protein stability, activation and degradation.

Figure 28. BLAST Analysis of PepZ Reveals Homology to Intracellular Leucine Specific
Aminopeptidases from Other Organisms. BLAST analysis of the amino acid sequence of PepZ
demonstrates homology to N-terminal cytoplasmic exopeptidases from the aminopeptidase family M17.
The M17 family of aminopeptidases includes the hexametric leucine aminopeptidases, which contain metal
ions within their catalytic domain.

The proteolytic processing of imported oligopeptides by cellular aminopeptidases is
important for nutrition and continued cell viability [Linderstrom-Lang, 1929; McDonald,
1986; Rawlings, 2004]. As such, we sought to investigate the role of PepZ in S. aureus
nutrition, using both peptide rich (milk) media and TSB. Growth analysis performed in
milk media using wild-type strains Newman and USA300 FPR, and their respective pepZ
mutants, identified similar growth profiles, with only one distinct phase of exponential
growth, indicating the use of free peptides only [Borezee-Durant et al., 2009]. Conversely,
previous observations identified decreased growth for Lactobacillus lactis cells lacking
aminopeptidase PepN when provided casein as a carbon source, necessitating the
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proteolytic activity of this aminopeptidase when grown in peptide rich media [Mierau et
al., 1996]. We therefore contend that PepZ is dispensable for growth in media where
peptides form the sole nitrogen source, possibly resulting from the redundant activities of
cellular peptidases or a potential function for growth in other specialized conditions or
environmental niches [Yen et al., 1980; Conlin and Miller, 1995].

Starvation analysis performed using cultures grown in aerated TSB also failed to identify
any changes in cell viability. This dispensable role for PepZ under these conditions
reflects previous observations in Salmonella typhimurium, which found that
aminopeptidase PepN did not contribute to growth in nutrient rich media [Patil et al.,
2007]. Conditions of growth were performed both static and shaking, to monitor the
effects of oxygen tension on PepZ, in accordance with previous observations associating
increased levels of oxygen with protease maturation and activation [Lindsay and Foster,
1999]. We found reduced survivability for pepZ mutant cells grown in milk under static
conditions after four weeks, or aerobic growth after one week. These results indicate the
aminopeptidase activity of PepZ is most important during the initial periods of long-term
starvation; consistent with the abundance of nutrients present during early time periods,
which dissipates over time as they are used by the cell. Indeed, nutritional analysis in L.
lactis identified that the starvation response is limited to the first few hours following
media carbohydrate exhaustion, which may indicate the presence of additional
mechanisms for cell survival under conditions of starvation in S. aureus [Otto et al., 1983;
Poolman and Konings, 1988]. Further, decreased growth rates of pepZ mutants cells
grown in milk possibly indicates reduced activities of oligopeptide transport systems, due
86

to the intracellular pooling of peptides in the absence of the peptidase [Mierau et al.,
1996]. In response to decreased protease activities for PepZ deficient cells, an
intracellular accumulation of unprocessed peptides is likely, reflecting a nutrient surplus
and decrease in the activities of oligopeptide transport systems. This type of regulation
has been observed in S. aureus, in which CodY, a negative regulator of genes involved in
amino acid synthesis and transport, was shown to repress oligopeptide transporters due to
the intracellular accumulation of branched-chain amino acids and GTP [Pohl et al., 2009].
A potential regulatory role for CodY on pepZ is supported in a study by Majerczyk et al.,
2010, which showed decreased expression of pepZ in a codY deficient S. aureus strain
[Majerczyk et al., 2010]. Interestingly, CodY has been shown to regulate the activation of
various virulence determinants as well, potentially associating PepZ with virulence. Cells
deficient in pepZ were also grown competitively in cocultures with their respective parent
strains, in either milk or TSB. The pepZ mutants showed decreased fitness in both
backgrounds when cultured either statically or while shaking, in peptide based media or
TSB. The impaired ability of pepZ mutant strains to compete for nutrients while in
coculture with S. aureus wild-types, suggests a possible intracellular proteolytic role for
PepZ and increased cellular fitness. Additionally, pepZ mutant cells grown in static
cocultures compared to shaking cocultures showed a greater ability to compete for
nutrients while in competition with the parent strain, possibly due to increased oxidative
stresses, associated with the greater oxygen levels. Therefore, one can conclude that PepZ
may negatively affect the ability of S. aureus to counteract oxidative stress. This
hypothesis is in accordance with our general stress analysis experiments, which identified
increased menadione resistance in a USA300 FPR pepZ mutant (15.6 mm) when
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compared to the parent (36 mm). Of note, previous research has shown that organisms
deficient in aminopeptidase activity are better placed for survival when some cellular
stresses are incurred. In E. coli, it was shown that aminopeptidase PepN negatively
regulates sodium-salicylate-induced stress, and the protease activity of PepN on certain
peptides may result in a decreased ability of the organism to resist such conditions
[Chandu and Nandi, 2003].

The role of PepZ during anaerobic growth was investigated using chemically defined
media, in accordance with previous observations that both oxygen and nutrient limiting
conditions impact aminopeptidase expression [Strauch et al., 1985; Jamieson and
Higgins, 1984]. The inability to proliferate when limited for amino acids in the absence
of oxygen was observed for both the Newman and USA300 FPR pepZ mutant strains
compared to the wild-type. Interestingly, NAD-specific glutamate dehydrogenase, a
protein that functions in amino acid degradation, was identified in our proteomic analysis
to be of greater abundance in USA300 FPR PepZ deficient intracellular proteomes
compared to the wild-type. Additionally, aminopeptidase PepA has been hypothesized to
maintain housekeeping roles, including amino acid recycling in E. coli and S.
typhimurium [Miller, 1996]. As such, these results suggest a potential intracellular role
for PepZ in peptide turn over and amino acid recycling during nutrient limiting
conditions.

Further, the USA300 FPR pepZ mutant showed impairment when grown under anaerobic
conditions limited for phosphate, compared to the wild-type. These results are similar to
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the reported increase in the transcription of aminopeptidase pepN in E. coli when
subjected to conditions of phosphate starvation, anaerobiosis, and growth in minimal
media [Gharbi et al., 1985]. In addition, the same study identified a slight impact on the
expression of aminopeptidase pepN by an alkaline phosphatase (AP) encoded in the pho
operon [Gharbi et al., 1985]. Alkaline phosphatase activity has previously been shown to
increase under phosphate limiting conditions [Horiuchi et al., 1959]. Indeed, AP is
typically synthesized during conditions of low phosphate, and repressed when it is
abundant. It is also produced by bacteria limited for organic carbon substrates, which are
the end product of phosphodiester hydrolysis [Hoppe, 2003; Hoppe and Ullrich, 1999].
Thus, it would be expected that alkaline phosphatase would be induced when grown on
chemically defined media and limited for various nutrients. It is therefore tempting to
speculate that pepZ expression is controlled by nutrient sensing regulators (such as CodY
and CcpA) in S. aureus and contributes to cell viability in environments deficient in
phosphate.

Interestingly, the failure of a USA300 FPR pepZ mutant to grow on MSA media under
conditions of anaerobiosis suggests either a role for PepZ in the utilization of mannitol or
osmotic stress. In Listeria monocytogenes, large accumulations of certain peptides
resulted from either high or low levels of osmolarity, with the accumulated peptides
found to contribute to osmoregulation [Maria-Rosario et al., 1995]. As such, the failure of
a pepZ mutant to grown on media containing elevated sodium chloride levels, MSA,
tends to suggest a possible role for PepZ in osmotic stress, resulting from an increase in
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intracellular peptides due to a deficiency in aminopeptidase activity, or in the utilization
of mannitol as a carbon source for nutrition.

The role of PepZ in protein degradation and turnover in response to protein denaturing
conditions was investigated using heat shock and adaptation experiments. We identified a
decreased capacity for survival in the Newman pepZ mutant strain compared to the wildtype strain, which suggests a role for PepZ at higher temperatures in the Newman
background. A previous study identified mutants defective in aminopeptidase PepS
produced a similar phenotype in response to elevated temperatures in Streptococcus
thermophilus, resulting from of decreased degradation of malformed proteins, negatively
affecting growth [Thomas et al., 2010].

Western blot analysis performed using proteomes collected from wild-type and pepZ
mutant strains at hours 5 and 15, identified PepZ in the secretome during both
exponential and post exponential growth. This subcellular localization of PepZ beyond
the cytoplasm indicates a probable extracellular role for this enzyme. The lack of an
identifiable signal sequence for PepZ does not preclude its potential for secretion and
possible extracellular activity. Specifically, Ess, a type VII-like secretion system
identified in S. aureus has been implicated in the development of staphylococcal
infections, and deficiencies in the Ess system demonstrated reduced virulence in mice
[Burts et al., 2008; Anderson et al., 2011]. As such, it appears that PepZ, while lacking an
identifiable signal sequence, could potentially be externalized by the Ess system, in
which the externalized protease activity could contribute towards virulence in S. aureus
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by potentially degrading host factors. Future work could seek to characterize the potential
for PepZ secretion by the Ess pathway using various methods of proteomic analysis to
identify potential protein-protein interactions.

Profiling of secreted and intracellular proteomes from USA300 FPR wild-type and pepZ
mutant strains using 2D-DIGE was performed on three hour cultures to elucidate how
PepZ fulfills its enzymatic role at the level of protein stability. 2D-DIGE secretome
analysis identified variations in protein molecular weight due to altered protein stability
in the absence of PepZ. Many of the proteins identified were found to be involved in cell
wall turnover and maintenance, nucleic acid processing and virulence [Fischer et al.,
1981; Oshida et al., 1995; Cuatrecasas et al., 1967; Tucker et al., 1978; Gillett et al.,
2002; Dunman et al., 2001]. A protein involved in the synthesis of the cell wall,
lipoteichoic acid synthase, was reduced in two spots by 1.57-fold and 1.56-fold, and
differentially processed in the absence of PepZ. It has been shown previously [Gründling
and Schneewind, 2007] that S. aureus cells lacking lipoteichoic acid synthase result in
defects in cell envelope and cell division. Further, a proposed function of lipoteichoic
acid includes targeting of autolysins to the bacterial envelope [Fischer et al., 1981]. Our
2D-DIGE analysis also found the major autolysin (Atl) to be reduced by 1.57 to 1.94-fold
in five different spots, with modified stability in the absence of PepZ. In S. aureus, Atl is
a bifunctional protein that must undergo proteolytic processing to release two functional,
lytic enzymes that participate in cell division and separation, cell lysis, and the release of
peptidoglycan at the cell surface [Foster, 1995; Oshida et al., 1995]. Interestingly, the Nterminal domain of Atl, an N- acetylmuramoyl-L-alanine amidase, was determined to be
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reduced by 1.49-fold to 1.72-fold from nine different spots in our 2D-DIGE analysis, and
have modified protein stability in PepZ deficient strains. Thus, it appears possible that
PepZ aids in cell wall turnover, corroborating our data from cell lysis experiments, which
demonstrate decreased membrane stability under lytic conditions for cells deficient in
PepZ.

2D-DIGE analysis performed on the cytoplasmic proteomes identified changes in protein
abundance and stability for various proteins involved in protein synthesis, amino acid
transport and metabolism, protein folding and degradation, peptide transport, and
virulence [Kuroda et al., 2001; Frees et al., 1999; Gaillot et al., 2000; Park et al., 1999;
Golonka et al., 2004, Highlander et al., 2007]. The wide range of functional roles for the
identified proteins, as well as the abundance of proteins (30) identified from only eleven
spots, demonstrates the limitations of this method of analysis. Image analysis performed
following the first method for protein separation, isoelectric focusing, produced
suboptimal protein separation patterns, with protein clustering at the acidic regions. As a
result, protein overlapping and clustering was observed due to incomplete separation.
This lack of protein separation can be attributed to the use of a broad pH range
immobilized pH gradient (IPG) strip for protein separation during isoelectric focusing.
IPG strips provide stable pH gradients for protein focusing according to the isoelectric
points of the proteins [Bjellqvistn et al., 1982]. Therefore, the use of narrow range IPG
strips allows proteins with similar isoelectric points to separate over a greater distance,
resulting in enhanced protein resolution, and added specificity for mass spectrometry
based protein identification [Issaq and Veenstra, 2008]. As such, the analysis of USA300
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FPR wild-type and PepZ mutant intracellular proteomes could be optimized with the use
of a narrow range IPG strip for greater specificity of proteins in the acidic pH range.

Strains deficient in pepZ were identified to be attenuated in both in vivo and in vitro
models of virulence. In vitro analysis performed using murine models of wound
formation and bacterial sepsis and dissemination, both demonstrated a significantly
attenuated ability of pepZ mutants to sustain infection. Further, Newman wild-type and
pepZ mutant cells were used to infect human macrophages, and a reduced survivability
was observed for cells lacking pepZ by 240-fold following 24 hours of incubation, and
129-fold following 48 hours, when compared to the parent strain. These results conflict
with a previous observation for aminopeptidase activity in S. typhimurium, in which a
pepN mutant was impaired in its ability to interact with components of the immune
system [Patil et al., 2007]. Collectively, these results suggest that the novel
aminopeptidase activity of PepZ is important for host immune system interaction and
evasion, and is required for full virulence in S. aureus, regardless of strain lineage. This
was determined using strain USA300 FPR, a CA-MRSA clinical strain and strain
Newman, a methicillin sensitive, MSSA, clinical strain, in the models of infections. The
use of a CA-MRSA model, USA300 FPR, allowed for the analysis of PepZ using a
current clinically relevant strain for analysis. The data we present herein suggests a
possible role for PepZ in the degradation of host factors that may control bacterial growth,
or potentially cleave a variety of secreted staphylococcal proteins that directly stimulate
and maintain intracellular infections. Proteases function in a wide variety of essential
regulatory and housekeeping functions, and secreted proteases regulate protein
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maturation and activation events. In S. aureus, proteases are secreted in a temporal
manner, many of which have been shown to contribute towards the progression of disease
[Chan and Foster, 1998; Karlsson and Arvidson, 2002; Lindsay and Foster, 1999;
McAleese et al., 2001; McGavin et al., 1997; Rice et al., 2001; Shaw et al., 2004].

S. aureus is a highly ubiquitous organism that has been implicated in a wide spectrum of
diseases ranging from skin and soft tissue infections to life threatening septicemia
[Lowry, 1998]. These manifestations of disease are the result of virulence factors
expressed by the organism, and include toxins, hemolysins, and proteases [Novick,
2006]. Typically, these are secreted factors which directly interact with the host during
infection, and facilitate invasion and colonization [Cheung et al., 1992, 2008; Janzon et
al., 1989; Peng et al., 1988]. In this study, we have demonstrated that PepZ, a novel
leucine-specific aminopeptidase is essential for pathogenesis in S. aureus, with no direct
role in S. aureus nutrition. The data presented here suggests that PepZ may function in
the degradation of host factors that may control bacterial growth, or potentially cleave a
variety of secreted staphylococcal proteins that directly stimulate and maintain
intracellular infections. Phenotypic characterization of PepZ has shown that S. aureus
strains deficient in the aminopeptidase have a decreased capacity for survival under stress
conditions associated with protein denaturing. These phenotypes tend to indicate a role
for PepZ in protein stability, activation and degradation, which could be associated with
the nutritional status of the cell via various regulatory proteins. This is in accordance with
transcriptional regulators such as CcpA and CodY that have been shown to link cell
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metabolism to the regulation of virulence determinants in S. aureus [Iyer et al., 2005;
Seidel et al., 2006; Abranches et al., 2008; Majerczyk et al., 2008].
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Future Directions

Future approaches for further elucidating the role of aminopeptidase PepZ in S. aureus
virulence could explore potential alterations in the global metabolism of wild-type and
pepZ deficient strains. This method of analysis would seek to identify potential substrates
of PepZ according to cellular metabolites. Additional characterization may seek to
explore the roles of the remaining twelve aminopeptidases in S. aureus for further insight
into the role of PepZ by virtue of the activity of the remaining peptidases. This method of
investigation could be performed through the construction of single and multiple
peptidase mutants, followed by nutritional analysis and phenotypic characterization
experiments. Future directions may also include the investigation of oligopeptide
transport systems to identify specific substrates for PepZ or peptide cleavage sites,
according to imported peptides and their subsequent processing by PepZ. Again, the
investigation of the transport systems could be performed through the construction of
single and multiple mutants in their respective genes, followed by nutritional analysis and
phenotypic characterization experiments. Further analysis of pepZ regulation by CodY
under conditions of limited nutrients could potentially clarify a role for the
aminopeptidase in S. aureus virulence. This method of analysis could be carried out using
murine models of infection to investigate the impact of a pepZ/codY double mutant on the
ability of S. aureus to cause infection. In addition, the construction of pepZ-lacZ reporter
fusion strains deficient in codY could explore the regulatory effects of CodY on pepZ
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expression, which could also be investigated using RT-PCR. Exploring the potential for
regulation of PepZ by CodY may identify regulatory roles for PepZ in transcription, in
accordance with previous reports that PepA, a M17 leucine specific aminopeptidase, was
found to regulate pyrimidine biosynthesis at the transcriptional level in E. coli [Charlier
et al., 2000].
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Appendix 1. Secreted Spots Determined by Mass Spectrometry Analysis to Have
Undetectable Protein Levels
Spot
2382
220
150
215
1155
279
310
188
458
2280
1277
2293
800
167
485
1661
2796
1609
2104
1601
1563
1078
3088
2216
2233
446
1729

Fold ∆
-6.31
-2.22
-1.84
-1.8
-1.69
-1.69
-1.66
-1.66
-1.63
-1.56
-1.55
-1.51
-1.5
-1.5
-1.33
1.41
1.53
1.54
1.59
1.71
1.71
1.92
2.02
2.72
2.89
3.26
7.8

*USA300 FPR wild-type and pepZ mutant 2D-DIGE secreted protein spots that mass spectrometry analysis
failed to detect protein for.
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